ASPH
aspartate beta-hydroxylase
ASPH; aspartate beta-hydroxylase; aspartyl/asparaginyl beta-hydroxylase; BAH; CASQ2BP1; HAAH; humbug; JCTN; junctate; junctin; ASP beta hydroxylase; Aspartyl/asparaginyl beta hydroxylase; Peptide aspartate beta dioxygenase; A beta H-J-J; cardiac junctin; ASP beta-hydroxylase; peptide-aspartate beta-dioxygenase; aspartyl/asparaginyl-beta-hydroxylase; AAH;
BCL2L11
BCL2-like 11 (apoptosis facilitator)
BCL2L11; BCL2-like 11 (apoptosis facilitator); bcl-2-like protein 11; bcl2-L-11; Bcl2 interacting mediator of cell death; bcl2-interacting mediator of cell death; Bim; Bod; 1500006F24Rik;
CST2
cystatin SA
CST2; cystatin SA; cystatin-SA; cystatin 2; cystatin-2; cystatin S5; cystatin-S5; cysteine-proteinase inhibitor; salivary cysteine (thiol) protease inhibitor; MGC71924;
CST3
cystatin C
CST3; cystatin C; ARMD11; cystatin-C; cystatin 3; cystatin-3; gamma-trace; post-gamma-globulin; bA218C14.4 (cystatin C); neuroendocrine basic polypeptide;
CST4
cystatin S
CST4; cystatin S; cystatin-S; Cystatin 4; Cystatin S precursor; Cystatin SA III; Cystatin-4; Cystatin-SA-III; CYTS_HUMAN; MGC71923; Salivary acidic protein 1; OTTHUMP00000030443;
CST5
cystatin D
CST5; cystatin D; cystatin-D; CST 5; Cystatin 5; CystatinD; Cysteine proteinase inhibitor; MGC71922; cystatin-5; cysteine-proteinase inhibitor;
CST6
cystatin E/M
CST6; cystatin E/M; cystatin-M; CST 6; Cystatin 6; Cystatin E; Cystatin M; Cystatin M/E; Cystatin-6; Cystatin-E; Cystatin6; CystatinE; CystatinM; Cysteine proteinase inhibitor; CYTM_HUMAN; OTTHUMP00000234150; ichq; N28197; 1110017E11Rik;
CST7
cystatin F (leukocystatin)
CST7; cystatin F (leukocystatin); cystatin-F; CMAP; Cystatin 7; Cystatin-like metastasis-associated protein; dJ568C11.1; Leukocystatin; cystatin-7; OTTHUMP00000030465;
CSTA
cystatin A (stefin A)
CSTA; cystatin A (stefin A); AREI; STF1; STFA; cystatin-A; cystatin AS; Stefin-A; CystatinAS; OTTHUMP00000215569;
CSTB
cystatin B (stefin B)
CSTB; cystatin B (stefin B); EPM1, STFB; cystatin-B; CST6; PME; CPI-B; liver thiol proteinase inhibitor; ULD; EPM1; STFB; EPM1A;
DFFA
DNA fragmentation factor, 45kDa, alpha polypeptide
DFFA; DNA fragmentation factor, 45kDa, alpha polypeptide; DFF1; ICAD; DFF-45; DNA fragmentation factor subunit alpha; DFF45; inhibitor of CAD; DNA fragmentation factor 45 kDa subunit;
ERCC1
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)
ERCC1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence); DNA excision repair protein ERCC-1; RAD10; UV20; COFS4;
ERCC3
excision repair cross-complementation group 3
ERCC3; excision repair cross-complementation group 3; XPB; BTF2; GTF2H; RAD25; TFIIH; TFIIH basal transcription factor complex helicase XPB subunit; BTF2 p89; TFIIH p89; TFIIH 89 kDa subunit; DNA excision repair protein ERCC-3; DNA repair protein complementing XP-B cells; basic transcription factor 2 89 kDa subunit; xeroderma pigmentosum, complementation group B; xeroderma pigmentosum group B-complementing protein; TFIIH basal transcription factor complex 89 kDa subunit; excision repair cross-complementing rodent repair deficiency, complementation group 3;
ERCC6
excision repair cross-complementing rodent repair deficiency, complementation group 6
ERCC6; excision repair cross-complementing rodent repair deficiency, complementation group 6; CSB; CKN2; COFS; ARMD5; COFS1; RAD26; DNA excision repair protein ERCC-6; Rad26 homolog; Cockayne syndrome B protein; ATP-dependent helicase ERCC6; cockayne syndrome protein CSB; Cockayne syndrome group B protein; OTTHUMP00000019581; EC 3.6.4.-; EC 3.6.1;
FOLH1
folate hydrolase (prostate-specific membrane antigen) 1
FOLH1; folate hydrolase (prostate-specific membrane antigen) 1; PSM; FGCP; FOLH; GCP2; PSMA; mGCP; GCPII; NAALAD1; NAALAdase; glutamate carboxypeptidase 2; NAALADase I; glutamate carboxylase II; glutamate carboxypeptidase II; membrane glutamate carboxypeptidase; cell growth-inhibiting gene 27 protein; folylpoly-gamma-glutamate carboxypeptidase; prostate specific membrane antigen variant F; pteroylpoly-gamma-glutamate carboxypeptidase; N-acetylated alpha-linked acidic dipeptidase 1; N-acetylated-alpha-linked acidic dipeptidase I;
FSTL1
follistatin-like 1
FSTL1; follistatin-like 1; follistatin-related protein 1; FRP; FSL1; follistatin-like protein 1; FLJ50214; FLJ52277;
Fstl3
follistatin-like 3 (secreted glycoprotein)
FSTL3; follistatin-like 3 (secreted glycoprotein); FLRG; FSRP; follistatin-related protein 3; follistatin-like protein 3; follistatin-related gene protein;
GAMT
Gamt guanidinoacetate methyltransferase
GAMT; guanidinoacetate methyltransferase; guanidinoacetate N-methyltransferase; Spintz1; AA571402;
GHRL
Ghrelin/Obestatin Prepropeptide
Ghrelin/obestatin prepropeptide; obestatin; ghrelin,growth hormone secretagogue receptor ligand; Growth hormone-releasing peptide; appetite-regulating hormone; Motilin related peptide; ghrelin/obestatin preprohormone; Growth hormone secretagogue; proteinM46; ghrelin; MTLRP; OTTHUMP00000207791; OTTHUMP00000207792; OTTHUMP00000207790; OTTHUMP00000207793; OTTHUMP00000207794; OTTHUMP00000207795; OTTHUMP00000207796; OTTHUMP00000207797; OTTHUMP00000207798; OTTHUMP00000226986; GHRL;
GOT1
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)
GOT1; glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1); aspartate aminotransferase, cytoplasmic; transaminase A; growth-inhibiting protein 18; glutamate oxaloacetate transaminase 1; GIG18; ASTQTL1;
GPX3
glutathione peroxidase 3 (plasma)
GPX3; glutathione peroxidase 3 (plasma); glutathione peroxidase 3; GPx-3; plasma glutathione peroxidase; extracellular glutathione peroxidase; GPx-P; GSHPx-3; GSHPx-P;
GSS
glutathione synthetase
GSS; glutathione synthetase; GSH-S; GSH synthetase; glutathione synthase; GSHS; MGC14098;
GSTA1
Glutathione S-transferase A1
Glutathione S alkyltransferase A1; Glutathione S aryltransferase A1; Glutathione S transferase 2; Glutathione S transferase A1; Glutathione S transferase alpha 1; Glutathione S transferase Ha subunit 1; Glutathione S-transferase A1; GST class-alpha member 1; GST epsilon; GST HA subunit 1; GST, class alpha, 1; GST-epsilon; GST2; GSTA1 1; GSTA1; GSTA1-1; GSTA1_HUMAN; GTH1; HA subunit 1; MGC131939; OTTHUMP00000016611; S (hydroxyalkyl)glutathione lyase A1;
GSTA3
glutathione S-transferase alpha 3
GSTA3; glutathione S-transferase alpha 3; glutathione S transferase A3; glutathione S-transferase A3; GST class-alpha member 3; glutathione S-transferase A3-3; glutathione S-aryltransferase A3; glutathione S-alkyltransferase A3; glutathione S-aralkyltrans;
GSTK1
glutathione S-transferase kappa 1
GSTK1; glutathione S-transferase kappa 1; GST13; GST class-kappa; glutathione S-transferase k1; glutathione S-transferase subunit 13 homolog; GST; hGSTK1; GSTK1-1; GST13-13; GST 13-13;
GSTM1
glutathione S-transferase mu 1
GSTA3; GST 3-3; GST Yb1; GSTM1-1; glutathione S-transferase M1; glutathione S-transferase Mu 1; glutathione S-transferase Yb-1 subunit; glutathione-S-transferase mu type 1 (Yb1); glutathione-S-transferase, mu type 1 (Yb1);
GSTM2
glutathione S-transferase mu 2 (muscle)
GSTM2; glutathione S-transferase mu 2 (muscle); glutathione S transferase M2 (muscle); glutathione S-transferase Mu 2; GST4; GST, muscle; GST class-mu 2; glutathione S-transferase 4; glutathione S-transferase M1; glutathione S-aryltransferase M2; glutathi;
GSTM4
glutathione S-transferase mu 4
GSTM4; glutathione S-transferase mu 4; glutathione S transferase M4; Glutathione S transferase Mu 4; GST class mu 4; GST class-mu 4; GST-Mu2; GSTM4 4; GSTM4-4; GSTM4_HUMAN; GTM4; GTS Mu2; MGC131945; MGC9247; GTS-Mu2; OTTHUMP00000013356; OTTHUMP00000013358; glutathione S-transferase M4; glutathione S-aryltransferase M4; glutathione S-alkyltransferase M4; glutathione S-aralkyltransferase M4; S-(hydroxyalkyl)glutath;
GSTO1
glutathione S-transferase omega 1
GSTO1; glutathione S-transferase omega 1; glutathione S-transferase omega-1; GSTTLp28; P28; AA407097; AI194287; AU018802; DKFZp686H13163; EC 2.5.1.18; Glutathione S transferase omega 1; Glutathione S-transferase omega 1-1; Glutathione S-transferase omega; Glutathione transferase omega 1; Glutathione-dependent dehydroascorbate reductase; Glutathione-S-transferase like; Glutathione-S-transferase omega 1; GSTO 1-1; GSTO1 1; GSTX; Gtsttl; MGC94845; OTTHUMP00000020429; GSTO-1; OTTHUMP00000020430; OTTHUMP00000020431;
GSTP1
glutathione S-transferase pi 1
GSTP1; glutathione S-transferase pi 1; FAEES3, GST3; glutathione S-transferase P; GSTP; GSTP1-1; GST class-pi; deafness, X-linked 7; fatty acid ethyl ester synthase III; PI; DFN7; GST3; FAEES3;
GSTT1
glutathione S-transferase theta 1
GSTT1; glutathione S-transferase theta 1; glutathione S-transferase theta-1; EC 2.5.1.18; Glutathione S transferase 5; Glutathione S transferase theta 1; Glutathione transferase T1 1; Glutathione transferase T1-1; GST 5 5; GST CL1; GST class theta 1; GST class-theta-1; GSTT1_HUMAN; OTTHUMP00000198547; OTTHUMP00000198549; EC 2.5.1.18; Glutathione S transferase 5; GST class-theta-1; GSTT1; Glutathione S Transferase theta 1; GST theta 1;
GSTZ1
glutathione transferase zeta 1
GSTZ1; glutathione transferase zeta 1; maleylacetoacetate isomerase; GSTZ1 1; MAAI; MAI; EC 2.5.1.18; EC 5.2.1.2; Glutathione S transferase zeta 1; GSTZ1-1; OTTHUMP00000246405; OTTHUMP00000246406; OTTHUMP00000246407; OTTHUMP00000246408; OTTHUMP00000246409; OTTHUMP00000246410; OTTHUMP00000246413; maleylacetone isomerase; glutathione S-aryltransferase; glutathione S-alkyltransferase; glutathi;
HAGH
hydroxyacylglutathione hydrolase
HAGH; hydroxyacylglutathione hydrolase; hydroxyacyl glutathione hydrolase; hydroxyacylglutathione hydrolase, mitochondrial; GLO2; GLXII; HAGH1; GLX II; Glyoxalase II; OTTHUMP00000158839; OTTHUMP00000158840; hydroxyacylglutathione hydroxylase; GLX2;
HTATIP2
HIV-1 Tat interactive protein 2, 30kDa
HTATIP2; HIV-1 Tat interactive protein 2, 30kDa; CC3; TIP30; SDR44U1; oxidoreductase HTATIP2; Tat-interacting protein (30kD); HIV-1 TAT-interactive protein 2; 30 kDa HIV-1 TAT-interacting protein; short chain dehydrogenase/reductase family 44U, member 1;
IL6ST
Interleukin 6 signal transducer (gp130, oncostatin M receptor)
IL6ST; CD130; CDW130; GP130; IL-6RB; Interleukin 6 signal transducer (gp130, oncostatin M receptor);
LDHA
lactate dehydrogenase A
LDHA; lactate dehydrogenase A; LDH1; LDHM; GSD11; PIG19; HEL-S-133P; L-lactate dehydrogenase A chain; LDH-A; LDH-M; LDH muscle subunit; lactate dehydrogenase M; proliferation-inducing gene 19; renal carcinoma antigen NY-REN-59; cell proliferation-inducing gene 19 protein; epididymis secretory sperm binding protein Li 133P;
LDHB
lactate dehydrogenase B
LDHB; lactate dehydrogenase B; L-lactate dehydrogenase B chain; LDH heart subunit; lactate dehydrogenase H chain; renal carcinoma antigen NY-REN-46; LDH-B; LDH-H; LDHBD; TRG-5;
Mstn
myostatin
MSTN; myostatin; GDF8; Growth/differentiation factor 8; GDF-8; OTTHUMP00000163498; growth differentiation factor 8;
NME2
non-metastatic cells 2, protein (NM23B) expressed in
NME2; non-metastatic cells 2, protein (NM23B) expressed in; nucleoside diphosphate kinase B; NM23 H2; NDP kinase B; c-myc transcription factor; histidine protein kinase NDKB; nucleotide diphosphate kinase B; c-myc purine-binding transcription factor PUF;
NME3
non-metastatic cells 3, protein expressed in
NME3; non-metastatic cells 3, protein expressed in; nucleoside diphosphate kinase 3; DR nm23; NM23 H3; NDK 3; NDP kinase 3; NDP kinase C; nucleoside diphosphate kinase C; NDPKC; NDPK-C; NM23H3; DR-nm23; NM23-H3; c371H6.2; KIAA0516;
NME4
non-metastatic cells 4, protein expressed in
NME4; non-metastatic cells 4, protein expressed in; nucleoside diphosphate kinase, mitochondrial; nm23 H4; NM23H4; NDK; NDPKD; NDP kinase D; NDP kinase, mitochondrial; nucleoside diphosphate kinase D; NDPK-D; nm23-H4;
NMI
N-myc (and STAT) interactor
NMI; N-myc (and STAT) interactor; N-myc-interactor; N-myc interactor;
OSMR
oncostatin M receptor
OSMR; oncostatin M receptor; oncostatin-M-specific receptor subunit beta; OSMRB; MGC140467; MGC150626; MGC150627; MGC75127; Oncostatin M specific receptor subunit beta; Oncostatin M-specific receptor, beta; IL-31RB; IL-31R-beta; IL-31R subunit beta; IL-31 receptor subunit beta; interleukin-31 receptor subunit beta; oncostatin-M specific receptor beta subunit; PLCA1;
PCMT1
protein-L-isoaspartate (D-aspartate) O-methyltransferase
PCMT1; protein-L-isoaspartate (D-aspartate) O-methyltransferase; protein-L-isoaspartate(D-aspartate) O-methyltransferase; L isoaspartyl protein carboxyl methyltransferase; L isoaspartyl/D aspartyl methyltransferase; PCMT 1; PIMT; Protein beta aspartate methyltransferase; Protein L isoaspartate (D aspartate) O methyltransferase; Protein L isoaspartyl/D aspartyl methyltransferase; OTTHUMP00000017397; OTTHUMP00000017398; OTTHUMP00000017400; protein-beta-aspartate methyltransferase; L-isoaspartyl protein carboxyl methyltransferase; protein L-isoaspartyl/D-aspartyl methyltransferase;
PIAS1
protein inhibitor of activated STAT, 1
PIAS1; protein inhibitor of activated STAT, 1; DDXBP1, DEAD/H (Asp Glu Ala Asp/His) box binding protein 1; E3 SUMO-protein ligase PIAS1; GBP; GU/RH II; zinc finger; MIZ type containing 3; ZMIZ3; gu-binding protein; AR interacting protein; DEAD/H box-bind;
PNPLA2
patatin-like phospholipase domain containing 2
PNPLA2; patatin-like phospholipase domain containing 2;
PNPLA3
patatin-like phospholipase domain containing 3
PNPLA3; patatin-like phospholipase domain containing 3; adiponutrin , ADPN, C22orf20, chromosome 22 open reading frame 20; patatin-like phospholipase domain-containing protein 3; adiponutrin; dJ796I17.1; FLJ22012; Acylglycerol O acyltransferase; ADPN; C22orf20; Calcium independent phospholipase A2 epsilon; iPLA(2)epsilon; Patatin like phospholipase domain containing 3; iPLA2-epsilon; OTTHUMP00000197822; OTTHUMP00000197823; acylglycerol O-acyltransferase; calcium-independent phospholipase A2-epsilon;
SLC2A1
solute carrier family 2 (facilitated glucose transporter), member 1
SLC2A1; solute carrier family 2 (facilitated glucose transporter), member 1; PED; DYT9; GLUT; DYT17; DYT18; EIG12; GLUT1; HTLVR; GLUT1DS; solute carrier family 2, facilitated glucose transporter member 1; GLUT-1; hepG2 glucose transporter; glucose transporter type 1, erythrocyte/brain; human T-cell leukemia virus (I and II) receptor;
STAT4
STAT4 signal transducer and activator of transcription 4
STAT4; signal transducer and activator of transcription 4;
STAT5A
STAT5A signal transducer and activator of transcription 5A
STAT5A; signal transducer and activator of transcription 5A; STAT5; MGF;
STMN1
STMN1 stathmin 1
STMN1; stathmin 1; C1orf215, chromosome 1 open reading frame 215 , LAP18, stathmin 1/oncoprotein 18; stathmin; FLJ32206; Lag; oncoprotein 18; OP18; PP17; PP19; PR22; SMN; prosolin; metablastin; phosphoprotein 19; phosphoprotein p19; stathmin 1/oncoprotein 18; transmembrane protein C1orf215; leukemia-associated phosphoprotein p18; LAP18; C1orf215; MGC138869; MGC138870;
STMN2
stathmin-like 2
STMN2; stathmin-like 2; SCGN10; stathmin-2; SCG10; Neuronal growth associated protein; Protein SCG10; SCG 10; SCG10 protein; SCGN 10; SGC 10; SGC10; Stathmin 2; Stathmin like 2; STMN 2; STMN2_HUMAN; Superior cervical ganglia neural specific 10; Superior cervical ganglion 10 protein; Superior cervical ganglion-10 protein; Superiorcervical ganglia neural specific 10; OTTHUMP00000226983; OTTHUMP00000226984; OTTHUMP00000227682; neuron-specific growth-associated protein; superior cervical ganglia, neural specific 10; neuronal growth-associated protein (silencer element);
STMN3
stathmin-like 3
STMN3; stathmin-like 3; stathmin-3; SCLIP; AI604839; R75323; RP23-83A14.1; SCG10-like protein; Scgn10 like protein; Stathmin like 3; OTTHUMP00000031570; SCG10-like-protein;
TAF1A
TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa
TAF1A; TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa; TATA box binding protein (TBP) associated factor, RNA polymerase I, A, 48kD; TATA box-binding protein-associated factor RNA polymerase I subunit A; SL1; TAFI48; RAFI48; TATA box binding protein associated factor 1A; TATA box binding protein associated factor RNA polymerase I subunit A; TBP associated factor RNA polymerase I 48 kDa; Transcription factor SL1; SL1, 48kD subunit; OTTHUMP00000035653; OTTHUMP00000035654; OTTHUMP00000035655; TBP-associated factor 1A; TATA box-binding protein-associated factor 1A; transcription; MGC:17061;
TBP
TATA binding protein
GTF2D,GTF2D1,HDL4,MGC117320,MGC126054,MGC126055,SCA17,TATA binding factor,TATA box factor,TATA sequence binding protein,TATA sequence-binding protein,TATA-binding factor,TATA-box binding protein N-terminal domain,TATA-box factor,TATA-box-binding protein,TBP,TBP_HUMAN,TFIID,Transcription initiation factor TFIID TBP subunit; TATA; binding protein TBP;
TSTA3
tissue specific transplantation antigen P35B
TSTA3; tissue specific transplantation antigen P35B; GDP-L-fucose synthase; FX; GDP L fucose synthase; P35B; SDR4E1; short chain dehydrogenase/reductase family 4E; member 1; 3 5 epimerase/4 reductase; anti TSTA3; EC 1.1.1.271; GDP 4 keto 6 deoxy D mannose 35 epimerase 4 reductase; GDP 4 keto 6 deoxy D mannose epimerase reductase; Protein FX; Red cell NADP(H) binding protein; Tissue specific transplantation antigen 3; OTTHUMP00000228670; OTTHUMP00000228671; OTTHUMP00000228672; 3-5 epimerase/4-reductase; red cell NADP(H)-binding protein; GDP-4-keto-6-deoxy-D-mannose epimerase-reductase; GDP-4-keto-6-deoxy-D-manno;
UBE2D4
ubiquitin-conjugating enzyme E2D 4 (putative)
UBE2D4; ubiquitin-conjugating enzyme E2D 4 (putative); ubiquitin-conjugating enzyme E2 D4; HBUCE1; HBUCE 1; UB2D4_HUMAN; UBE2D 4; Ubiquitin carrier protein D4; Ubiquitin conjugating enzyme 1 isoform; Ubiquitin-protein ligase D4; OTTHUMP00000159220; OTTHUMP00000207576; ubiquitin-conjugating enzyme HBUCE1;
UBE2T
ubiquitin-conjugating enzyme E2T (putative)
UBE2T; ubiquitin-conjugating enzyme E2T (putative); ubiquitin-conjugating enzyme E2 T; HSPC150; ubiquitin-protein ligase T; ubiquitin carrier protein T; ubiquitin conjugating enzyme; cell proliferation-inducing gene 50 protein; HSPC150 protein similar to ubiquitin-conjugating enzyme; PIG50;
ACPP
Acid Phosphatase, Prostate
ACPP; acid phosphatase, prostate; PAP; ACP3; ACP-3; prostatic acid phosphatase; OTTHUMP00000216106; OTTHUMP00000216107; OTTHUMP00000216108;
ATM
ataxia telangiectasia mutated
ATM; ataxia telangiectasia mutated; ATA, ataxia telangiectasia mutated (includes complementation groups A, C and D) , ATC, ATD, ATDC; serine-protein kinase ATM; TEL1; telomere maintenance 1; homolog (S. cerevisiae); TELO1; AT mutated; A-T mutated; TEL1,;
GRIN1
glutamate receptor, ionotropic, N-methyl D-aspartate 1
GRIN1; glutamate receptor, ionotropic, N-methyl D-aspartate 1; NR1; MRD8; GluN1; NMDA1; NMDAR1; glutamate receptor ionotropic, NMDA 1; NMD-R1; glutamate [NMDA] receptor subunit zeta 1; glutamate [NMDA] receptor subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; N-methyl-D-aspartate receptor channel, subunit zeta-1;
GRIN2B
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
GRIN2B; glutamate receptor, ionotropic, N-methyl D-aspartate 2B; MRD6; NR2B; hNR3; GluN2B; NMDAR2B; glutamate receptor ionotropic, NMDA 2B; NR3; glutamate receptor subunit epsilon-2; N-methyl-D-aspartate receptor subunit 3; N-methyl D-aspartate receptor subtype 2B; glutamate [NMDA] receptor subunit epsilon-2;
TAF12
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa
TAF12; TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa; TAF2J, TATA box binding protein (TBP) associated factor, RNA polymerase II, J, 20kD; transcription initiation factor TFIID subunit 12; TAFII20; TAF15; TAF2J; TAFII 20/TAFII 15; TAFII20/TAFII15; Transcription initiation factor TFIID 20/15 kDa subunits; TAFII-20/TAFII-15; OTTHUMP00000003785; OTTHUMP00000003786; TATA box binding protein (TBP)-associated factor, RNA polymerase II, J, 20kD;
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
CAD; carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; CAD protein; CAD trifunctional protein; multifunctional protein CAD;
CBS
cystathionine-beta-synthase
CBS; cystathionine-beta-synthase; cystathionine beta-synthase; HIP4; beta-thionase; serine sulfhydrase; methylcysteine synthase;
CTH
cystathionase (cystathionine gamma-lyase)
CTH; cystathionase (cystathionine gamma-lyase); cystathionine gamma-lyase; gamma-cystathionase; homoserine deaminase; cysteine desulfhydrase; homoserine dehydratase; cysteine-protein sulfhydrase; MGC9471;
DHODH
dihydroorotate dehydrogenase (quinone)
DHODH; dihydroorotate dehydrogenase (quinone); dihydroorotate dehydrogenase; dihydroorotate dehydrogenase (quinone), mitochondrial; dihydroorotate oxidase; human complement of yeast URA1; URA1; POADS; DHOdehase;
ENPP5
ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)
ENPP5; ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative); ectonucleotide pyrophosphatase/phosphodiesterase family member 5; E-NPP5; NPP-5; E-NPP 5; OTTHUMP00000016542; OTTHUMP00000016543; ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative function);
ENTPD6
ectonucleoside triphosphate diphosphohydrolase 6 (putative)
ENTPD6; ectonucleoside triphosphate diphosphohydrolase 6 (putative); CD39L2, IL6ST2, interleukin 6 signal transducer 2; ectonucleoside triphosphate diphosphohydrolase 6; dJ738P15.3; NTPDase 6; CD39-like 2; CD39 antigen-like 2; HCV-E2 binding protein 1; i;
ERCC6L
excision repair cross-complementing rodent repair deficiency, complementation group 6-like
ERCC6L; excision repair cross-complementing rodent repair deficiency, complementation group 6-like; DNA excision repair protein ERCC-6-like; FLJ20105; PICH; PLK1 interacting checkpoint helicase; tumor antigen BJ-HCC-15; SNF2/RAD54 family protein; ATP-dependent helicase ERCC6-like; excision repair protein ERCC6-like; Plk1-interacting checkpoint helicase; excision repair cross-complementing rodent repair deficiency complementation group 6 - like; MGC131695;
ERCC8
excision repair cross-complementing rodent repair deficiency, complementation group 8
ERCC8; excision repair cross-complementing rodent repair deficiency, complementation group 8; CKN1, Cockayne syndrome 1 (classical); DNA excision repair protein ERCC-8; CSA; Cockayne syndrome WD-repeat protein CSA; cockayne syndrome WD repeat protein CSA;
FANCC
Fanconi anemia, complementation group C
FANCC; Fanconi anemia, complementation group C; FACC; Fanconi anemia group C protein; FA3; FAC; FLJ14675;
FANCG
Fanconi anemia, complementation group G
FANCG; Fanconi anemia, complementation group G; FAG; XRCC9; Fanconi anemia group G protein; DNA repair protein XRCC9; X-ray repair, complementing defective, in Chinese hamster, 9; X-ray repair complementing defective repair in Chinese hamster cells 9;
FUT2
fucosyltransferase 2 (secretor status included)
FUT2; fucosyltransferase 2 (secretor status included); SE; galactoside 2-alpha-L-fucosyltransferase 2; alpha (1; 2) fucosyltransferase; alpha(1; 2)FT2; galactoside 2 alpha L fucosyltransferase 2; GDP L fucose:beta D galactoside 2 alpha L fucosyltransferase 2; Se2; SEC2; secretor blood group alpha 2 fucosyltransferase; secretor factor; sej; Fucosyltransferase 2; alpha(1,2)FT2; alpha(1,2)FT 2; OTTHUMP00000226681; OTTHUMP00000226682; alpha (1,2) fucosyltransferase; secretor blood group alpha-2-fucosyltransferase; GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosylt; B12QTL1;
GK5
glycerol kinase 5 (putative)
GK5; glycerol kinase 5 (putative); putative glycerol kinase 5; MGC40579; ATP:glycerol 3-phosphotransferase 5; FLJ33582; FLJ45739; Glycerokinase 5; GK 5;
GOT2
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)
GOT2; glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2); aspartate aminotransferase, mitochondrial; KAT4; KATIV; kynurenine aminotransferase IV; mitAAT; ASPATA; FABP pm; Got 2; MGC102129; MGC115763; mitochondrial; AATM_HUMAN; AL022787; Aspartate aminotransferase; Aspartate aminotransferase 2; EC 2.6.1.1; FABP 1; FABP-1; FABPpm; Fatty acid binding protein; Fatty acid-binding protein; FLJ40994; Glutamate oxaloacetate transaminase 2; Glutamate oxaloacetate transaminase 2, mitochondrial; Glutamate oxaloacetate transaminase, mitochondrial; Glutamic oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2); mAspAT; Mitochondrial aspartate aminotransferase; OTTMUSP00000017748; Plasma membrane fatty acid binding protein; Plasma membrane-associated fatty acid-binding protein; Transaminase A;
GSR
glutathione reductase
GSR; glutathione reductase; HEL-75; glutathione reductase, mitochondrial; GR; GRase; epididymis luminal protein 75;
GSTA6P
Glutathione S-transferase Alpha 6, Pseudogene
GSTA6P; GSTAP1; glutathione S-transferase alpha 6, pseudogene; glycogen synthase kinase 3 beta; GSK-3 beta; GSK3beta isoform;glycogen synthase kinase-3 beta; EC 2.7.11.26;
GSTM5
glutathione S-transferase mu 5
GSTM5; glutathione S-transferase mu 5; glutathione S transferase M5; Glutathione S alkyltransferase M5; Glutathione S aralkyltransferase M5; Glutathione S aryltransferase M5; Glutathione S transferase Mu 5; GST class mu 5; GST class-mu 5; GSTM 5; GSTM5 5; GSTM5-5; GSTM5_HUMAN; GTM 5; GTM5; OTTHUMP00000013359; OTTHUMP00000013361; S (hydroxyalkyl)glutathione lyase M5; glutathione S-transferase M5; glutathione S-aryltransferase M5; glutathione S-alkyltransferase M5; glutathione S-aralkyltransferase M5; S-(hydroxyalkyl)glutathione lyase M5;
LDHAL6B
lactate dehydrogenase A-like 6B
LDHAL6B; lactate dehydrogenase A-like 6B; lactate dehydrogenase A like 6 , LDHAL6; L-lactate dehydrogenase A-like 6B; LDH6B; LDHL; L lactate dehydrogenase A like 6B; lactate dehydrogenase A like 6; lactate dehydrogenase A like; LDHAL6; OTTHUMP00000163569; lactate dehydrogenase A-like 6;
LDHC
lactate dehydrogenase C
LDHC; lactate dehydrogenase C; L-lactate dehydrogenase C chain; LDH-C; LDH testis subunit; lactate dehydrogenase-X; lactate dehydrogenase 3, C chain, sperm specific; Ldh3; Ldh-3; Ldh-x; Ldhc4; LDH-C4;
MCC
mutated in colorectal cancers
MCC; mutated in colorectal cancers; colorectal mutant cancer protein; DKFZp762O1615; FLJ38893; FLJ46755; MCC 1; MCC1; Protein MCC; OTTHUMP00000159017; OTTHUMP00000222860; OTTHUMP00000223206;
PINK1
PTEN induced putative kinase 1
PINK1; PTEN induced putative kinase 1; BRPK; PARK6; FLJ27236; Parkinson disease (autosomal recessive) 6; Serine/threonine-protein kinase PINK1, mitochondrial; PTEN-induced putative kinase protein 1; OTTHUMP00000002881; protein kinase BRPK;
PMEPA1
prostate transmembrane protein, androgen induced 1
PMEPA1; prostate transmembrane protein, androgen induced 1; TMEPAI, transmembrane, prostate androgen induced RNA; transmembrane prostate androgen-induced protein; solid tumor associated 1; STAG1; solid tumor-associated 1 protein; transmembrane, prostate;
SHOX2
short stature homeobox 2
SHOX2; short stature homeobox 2; short stature homeobox protein 2; OG12; OG12X; SHOT; Homeobox protein Og12X; OG 12; OG 12X; OGI 2X; OGI2X; Paired related homeobox protein SHOT; Paired-related homeobox protein SHOT; Short stature homeobox homolog; SHOX 2; SHOX homologous gene on chromosome 3; SHOX2_HUMAN; OTTHUMP00000213397; OTTHUMP00000213398; OTTHUMP00000213399; OTTHUMP00000245277;
SLC2A4
solute carrier family 2 (facilitated glucose transporter), member 4
SLC2A4; solute carrier family 2 (facilitated glucose transporter), member 4; GLUT4; solute carrier family 2, facilitated glucose transporter member 4; GLUT-4; OTTHUMP00000128376; insulin-responsive glucose transporter type 4; glucose transporter type 4, insulin-responsive;
STEAP1
six transmembrane epithelial antigen of the prostate 1
STEAP1; six transmembrane epithelial antigen of the prostate 1; six transmembrane epithelial antigen of the prostate , STEAP; metalloreductase STEAP1; PRSS24; six-transmembrane epithelial antigen of prostate 1; STEAP; MGC19484;
TAF1
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
TAF1; TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa; OF; XDP; BA2R; CCG1; CCGS; DYT3; KAT4; P250; NSCL2; TAF2A; N-TAF1; TAFII250; DYT3/TAF1; TAFII-250; TAF(II)250; transcription initiation factor TFIID subunit 1; cell cycle gene 1 protein; cell cycle, G1 phase defect; TBP-associated factor 250 kDa; transcription factor TFIID p250 polypeptide; complementation of cell cycle block, G1-to-S;
TAF11
TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa
TAF11; TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa; TAF2I, TATA box binding protein (TBP) associated factor, RNA polymerase II, I, 28kD; transcription initiation factor TFIID subunit 11; TAFII28; TAFII-28; TAF(II)28;
TAF1C
TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa
TAF1C; TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa; TATA box binding protein (TBP) associated factor, RNA polymerase I, C, 110kD; TATA box-binding protein-associated factor RNA polymerase I subunit C; MGC:39976; SL1; TAFI;
TAF1L
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like
TAF1L; TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like; TAF1 like RNA polymerase II, TATA box binding protein (TBP) associated factor, 210kDa; transcription initiation factor TFIID subunit 1-like; TAF(II)210; TBP-asso;
TAF7
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa
TAF7; TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa; TAF2F, TATA box binding protein (TBP) associated factor, RNA polymerase II, F, 55kD; transcription initiation factor TFIID subunit 7; TAFII55; TAFII-55; TAF(II)55; TBP;
TMEFF2
transmembrane protein with EGF-like and two follistatin-like domains 2
TMEFF2; transmembrane protein with EGF-like and two follistatin-like domains 2;
UBR3
ubiquitin protein ligase E3 component n-recognin 3 (putative)
UBR3; ubiquitin protein ligase E3 component n-recognin 3 (putative); zinc finger protein 650 , ZNF650; E3 ubiquitin-protein ligase UBR3; DKFZp434P117; FLJ37422; KIAA2024; DKFZp686N10185; MGC126489; Zinc finger protein 650; ZNF 650; N-recognin-3; OTTHUMP00000163072; ubiquitin-protein ligase E3-alpha-3; ubiquitin-protein ligase E3-alpha-III; ZNF650;
XPC
xeroderma pigmentosum, complementation group C
XPC; xeroderma pigmentosum, complementation group C; DNA repair protein complementing XP-C cells; RAD4; xeroderma pigmentosum group C protein; XPCC; p125; mutant xeroderma pigmentosum group C; XP3;
DFFB
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
DFFB; DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase); CAD; CPAN; DFF2; DFF40; DFF-40; DNA fragmentation factor subunit beta; caspase-activated DNase; caspase-activated nuclease; caspase-activated deoxyribonuclease; DNA fragmentation factor 40 kDa subunit;
GPX4
glutathione peroxidase 4
GPX4; glutathione peroxidase 4; MCSP; GPx-4; PHGPx; snGPx; GSHPx-4; snPHGPx; phospholipid hydroperoxide glutathione peroxidase, mitochondrial; phospholipid hydroperoxidase; sperm nucleus glutathione peroxidase;
GPX1
glutathione peroxidase 1
GPX1; glutathione peroxidase 1; GPx-1; GSHPx-1; cellular glutathione peroxidase; GPXD; GSHPX1; MGC14399; MGC88245;
GST
Glutathione-S-Transferase
GST; Glutathione-S-Transferase; Glutathione S alkyltransferase A1; Glutathione S aralkyltransferase A1; Glutathione S aryltransferase A1; Glutathione S transferase 2; Glutathione S transferase A1; Glutathione S-transferase A1; GST 2; GST class alpha; GST class alpha 1; GST class alpha member 1; GST class-alpha member 1; GST epsilon; GST HA subunit 1; GST-epsilon; GST2; GSTA 1; GSTA1 1; GSTA1; GSTA1 protein; GSTA1-1; GSTA1_HUMAN; GTH 1; GTH1; HA subunit 1; MGC131939; S (hydroxyalkyl) glutathione lyase A1; Glutathione S Transferase ; Glutathione S transferase Mu 1 ; Glutathione S-transferase class-mu 26 kDa isozyme ; Gluthatione s transferase ; GST 26 ; GST ; GST class mu 1 ; GST1 ; GSTM1 1 ; GSTM1a 1a ; GSTM1b 1b ; GTH4 ; GTM1 ; H B ; HB subunit 4 ; MGC26563 ; MU 1 ; MU ; SJ26 antigen ; SjGST ;
GSTA4
glutathione S-transferase alpha 4
GSTA4; glutathione S-transferase alpha 4; glutathione S transferase A4; glutathione S-transferase A4; DKFZp686D21185; Glutathione S alkyltransferase A4; Glutathione S aralkyltransferase A4; Glutathione S aryltransferase A4; Glutathione S transferase A4 4; Glutathione S transferase alpha 4; Glutathione S-transferase A4-4; Glutathione transferase A4 4; GST class alpha member 4; GST class-alpha member 4; GSTA4 4; GSTA4_HUMAN; GTA4; OTTHUMP00000016624; OTTHUMP00000016625; S (hydroxyalkyl)glutathione lyase A4; glutathione transferase A4-4; glutathione S-aryltransferase A4; glutathione S-alkyltransferase A4; glutathione S-aralkyltransferase A4; S-(hydroxyalkyl)glutathione lyase A4; GSTA4-4;
GSTT2
glutathione S-transferase, theta 2
GSTT2; glutathione S-transferase, theta 2; glutathione S-transferase theta-2; EC 2.5.1.18; Glutathione S transferase 12; Glutathione S transferase Yrs Yrs; Glutathione S-transferase theta-2B; GST 12 12; GST class theta 2; GST class-theta-2; GST T2; GSTT 2; GSTT2 protein; GSTT2_HUMAN; GSTT2B; MGC182032; OTTHUMP00000198491; OTTHUMP00000198492; Yrs; mGSTT2; AI266894;
SLC2A6
solute carrier family 2 (facilitated glucose transporter), member 6
SLC2A6; solute carrier family 2 (facilitated glucose transporter), member 6; solute carrier family 2, facilitated glucose transporter member 6; GLUT6; GLUT9; HSA011372; A330096C23; F630103L12Rik; Glucose transporter type 6; Glucose transporter type 9; GLUT-6; GLUT-9; GTR6_HUMAN; RP23-449M10.2;
FAHD2A
fumarylacetoacetate hydrolase domain containing 2A
FAHD2A; fumarylacetoacetate hydrolase domain containing 2A; fumarylacetoacetate hydrolase domain-containing protein 2A; CGI 105; FAH2A_HUMAN; FAHD 2A; Fumarylacetoacetate hydrolase domain containing 1; Fumarylacetoacetate hydrolase domain containing protein 2A; MGC131995; OTTHUMP00000207352; CGI-105;
ERCC4
excision repair cross-complementing rodent repair deficiency, complementation group 4
ERCC4; excision repair cross-complementing rodent repair deficiency, complementation group 4; XPF; DNA repair endonuclease XPF; RAD1; xeroderma pigmentosum; complementation group F; DNA excision repair protein ERCC-4; DNA repair protein complementing XP-F;
ILVBL
ilvB (bacterial acetolactate synthase)-like
ILVBL; ilvB (bacterial acetolactate synthase)-like; acetolactate synthase-like protein; 209L8; acetolactate synthase homolog; AHAS; FLJ39061; ILV2H; MGC1269; MGC19535; Acetolactate synthase like protein; IlvB (bacterial acetolactate synthase) like; IlvB like protein; IlvB-like protein; ILVBL_HUMAN;
SLC2A5
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
SLC2A5; solute carrier family 2 (facilitated glucose/fructose transporter), member 5; GLUT5; GLUT-5; solute carrier family 2, facilitated glucose transporter member 5; glucose transporter-like protein 5; glucose transporter type 5, small intestine;
CST1
cystatin SN
CST1; cystatin SN; cystatin-SN; Cystain SAI; Cystain-SA-I; Cystatin 1; Cystatin-1; Cystatin1; CYTN; CYTN_HUMAN; Salivary cystatin SA1; Salivary cystatin-SA-1; cystatin SA-I; cysteine proteinase inhibitor, type 2 family;
WFIKKN2
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
WFIKKN2;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2;WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2;WFIKKNRP;WFIKKN-related protein;multivalent protease inhibitor protein;WAP, FS, Ig, two KU and NTR module related protein;growth and differentiation factor-associated serum protein 1;WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-related protein;GASP-1;hGASP-1;
DERA
deoxyribose-phosphate aldolase (putative)
DERA; deoxyribose-phosphate aldolase (putative); 2 deoxyribose 5 phosphate aldolase homolog (C. elegans); putative deoxyribose-phosphate aldolase; CGI 26; DEOC; Deoxyriboaldolase; 2 deoxyribose 5 phosphate aldolase homolog C. elegans; CGI26; DEOC_HUMAN; Deoxyribose phosphate aldolase like; Phosphodeoxyriboaldolase; Putative deoxyribose phosphate aldolase; 2-deoxy-D-ribose 5-phosphate aldolase; 2-deoxyribose-5-phosphate aldolase homolog; CGI-26;
BCL2L10
BCL2-like 10 (apoptosis facilitator)
BCL2L10; BCL2-like 10 (apoptosis facilitator); bcl-2-like protein 10; BCL B; Boo; Diva; bcl2-L-10; apoptosis regulator Bcl-B; anti-apoptotic protein NrH; BCL-B; MGC129810; MGC129811;
BCL2L13
BCL2-like 13 (apoptosis facilitator)
BCL2L13; BCL2-like 13 (apoptosis facilitator); bcl-2-like protein 13; BCL RAMBO; MIL1; Protein Mil1; BCL-RAMBO; Bcl2-L-13;
BCL2L14
BCL2-like 14 (apoptosis facilitator)
BCL2L14; BCL2-like 14 (apoptosis facilitator); apoptosis facilitator Bcl-2-like protein 14; BCL G; BCLG; bcl2-L-14; apoptosis regulator BCL-G;
DDO
D-aspartate oxidase
DDO; D-aspartate oxidase; D aspartate oxidase; DASOX; DDO 1; DDO 2; FLJ45203; OTTHUMP00000017000; aspartic oxidase; D-aspartate oxidase, DDO; DDO-1; DDO-2;
ERCC2
excision repair cross-complementing rodent repair deficiency, complementation group 2
ERCC2; excision repair cross-complementing rodent repair deficiency, complementation group 2; xeroderma pigmentosum complementary group D , XPD; TFIIH basal transcription factor complex helicase XPD subunit; EM9; excision repair cross complementing rodent;
FAH
fumarylacetoacetate hydrolase (fumarylacetoacetase)
FAH; fumarylacetoacetate hydrolase (fumarylacetoacetase); fumarylacetoacetase; FAA; beta-diketonase; FLJ51912;
FANCA
Fanconi anemia, complementation group A
FANCA; Fanconi anemia, complementation group A; FACA, FANCH; Fanconi anemia group A protein; FA H; FAA; FAH; Fanconi anemia, type 1; Fanconi anemia, complementation group H; FA; FA1; FA-H; FACA; FANCH; MGC75158;
FANCB
Fanconi anemia, complementation group B
FANCB; Fanconi anemia, complementation group B; Fanconi anemia group B protein; FAAP95; FAB; FLJ34064; Fanconi anemia-associated polypeptide of 95 kDa; FA2; FACB; FAAP90;
FANCD2
Fanconi anemia, complementation group D2
FANCD2; Fanconi anemia, complementation group D2; FA4; FAD; FACD; FAD2; FA-D2; FANCD; Fanconi anemia group D2 protein;
FANCF
Fanconi anemia, complementation group F
FANCF; Fanconi anemia, complementation group F; FAF; Fanconi anemia group F protein;
GPX5
glutathione peroxidase 5 (epididymal androgen-related protein)
GPX5;glutathione peroxidase 5 (epididymal androgen-related protein);epididymal secretory glutathione peroxidase;EGLP;GPx-5;GSHPx-5;epididymal androgen-related protein;epididymis-specific glutathione peroxidase-like protein;
GPX6
glutathione peroxidase 6 (olfactory)
GPX6; glutathione peroxidase 6 (olfactory); glutathione peroxidase pseudogene 3 , GPXP3;
GRINL1A
glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A
glutamate receptor, ionotropic, N-methyl D-aspartate-like 1A; Glutamate receptor-like protein 1A; DKFZp586F1918; GRINL1A downstream protein Gdown4; protein GRINL1A; protein GRINL1A, isoforms 4/5; OTTHUMP00000163345; OTTHUMP00000163421;
GSTA2
glutathione S-transferase alpha 2
GSTA2; glutathione S-transferase alpha 2; glutathione S transferase A2 , GST2; glutathione S-transferase A2; EC 2.5.1.18; Glutathione S transferase 2; Glutathione S transferase A2; Glutathione S-alkyltransferase A2; Glutathione S-aralkyltransferase A2; Glutathione S-aryltransferase A2; Glutathione S-transferase GT41A; Glutathione S-transferase Ya-2; Glutathione S-transferase, alpha 2 (Yc2); GST 1b-1b; GST A2-2; GST class alpha member 2; GST gamma; GST Ya2; GST, class alpha, 2; GST2; Gst2-2; GSTA2 2; GSTA2-2; Gstc-2; Gstc2; GTA2; GTH2; HA subunit 2; Liver GST2; MGC10525; OTTHUMP00000017883; S-(hydroxyalkyl)glutathione lyase A2; GST-gamma; GST HA subunit 2; GST class-alpha member 2;
GSTM3
glutathione S-transferase mu 3 (brain)
GSTM3; glutathione S-transferase mu 3 (brain); glutathione S transferase M3 (brain); glutathione S-transferase Mu 3; GST5; brain GST; brain type mu glutathione S transferase; glutathione S alkyltransferase M3; glutathione S aryltransferase M3; glutathione S transferase M3; Glutathione S transferase Mu 3; glutathione S transferase, Mu 3; GST class mu 3; GST class-mu 3; GSTB; GSTM3-3; GSTM3_HUMAN; GTM3; hGSTM3-3; MGC3310; MGC3704; S (hydroxyalkyl)glutathione lyase M3; glutathione S-transferase, Mu-3; glutathione S-aryltransferase M3; glutathione S-alkyltransferase M3; glutathione S-aralkyltransferase M3; S-(hydroxyalkyl)glutathione lyase M3; glutathione S-transferase M3 (brain); brain type mu-glutathione S-transferase;
HTN3
histatin 3
HTN3;histatin 3;histatin-3;HIS2;PB;hst;histatin 5;histidine-rich protein 3;basic histidine-rich protein;HTN2;HTN5;
HYI
hydroxypyruvate isomerase (putative)
HYI; hydroxypyruvate isomerase (putative); hydroxypyruvate isomerase homolog (E. coli); putative hydroxypyruvate isomerase; HT036; hydroxypyruvate isomerase homolog; endothelial cell apoptosis protein E-CE1; MGC20767; RP11-506B15.5;
MGST2
microsomal glutathione S-transferase 2
MGST2; microsomal glutathione S-transferase 2; MGST II; FLJ27438; GST 2; GST2; MGC14097; MGST 2; MGSTII; Microsomal glutathione S transferase 2; Microsomal GST 2; Microsomal GST II; microsomal GST-2; microsomal GST-II; MGST-II;
MGST3
microsomal glutathione S-transferase 3
MGST3; microsomal glutathione S-transferase 3; GST III; microsomal glutathione S transferase III; microsomal GST 3; microsomal GST III; MGST3_HUMAN; Microsomal glutathione S transferase 3; Microsomal GST-3; Microsomal GST-III; Microsomal GST3; Microsomal GSTIII; microsomal glutathione S-transferase III; GST-III;
N6AMT1
N-6 adenine-specific DNA methyltransferase 1 (putative)
N6AMT1; N-6 adenine-specific DNA methyltransferase 1 (putative); C21orf127, chromosome 21 open reading frame 127 , HemK methyltransferase family member 2 , HEMK2; hemK methyltransferase family member 2; MTQ2; N6AMT; PRED28; C21orf127; Chromosome 21 open reading frame 127; EC 2.1.1.-; HemK2; M.HsaHemK2P; MGC19995; N-6 adenine-specific DNA methyltransferase 1; N6-DNA-methyltransferase; OTTHUMP00000096393; OTTHUMP00000096394; OTTHUMP00000096395; n(6)-adenine-specific DNA methyltransferase 1;
NAT8B
N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)
NAT8B; N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene); N acetyltransferase 8B (gene/pseudogene); probable N-acetyltransferase 8B; Hcml2; NAT8BP; Camello like protein 2; Camello-like protein 2; CML2; N acetyltransferase 8B; NAT8B_HUMAN; Probable N acetyltransferase 8B; N-acetyltransferase Camello 2; N-acetyltransferase 8B (gene/pseudogene);
NME6
non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase)
NME6; non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 6; IPIA ALPHA; NM23 H6; NDP kinase 6; inhibitor of p53-induced apoptosis-alpha; NDK 6; NM23-H6; IPIA-ALPHA;
PAGE1
P antigen family, member 1 (prostate associated)
PAGE1; P antigen family, member 1 (prostate associated); G antigen, family B, 1 (prostate associated) , GAGEB1; G antigen family B member 1; CT16.3; GAGE 9; PAGE 1; G antigen 9; prostate associated gene 1; prostate-associated gene 1 protein; G antigen, fa;
PAGE4
P antigen family, member 4 (prostate associated)
PAGE4; P antigen family, member 4 (prostate associated); G antigen, family C, 1 , GAGEC1; G antigen family C member 1; CT16.7; PAGE 4; FLJ35184; G antigen family C 1; GAGE 9; GAGE9; GAGEC1; JM 27; JM27; P antigen family member 4 (prostate associated); P antigen family member 4; PAGE 1; PAGE1; Prostate associated gene 4 protein; Prostate associated gene protein 4; G antigen, family C, 1; prostate-associated gene 4 protein; prostate-associated gene protein 4; JM-27; GAGE-9; PAGE-1; PAGE-4;
PIAS2
protein inhibitor of activated STAT, 2
PIAS2; protein inhibitor of activated STAT, 2; E3 SUMO-protein ligase PIAS2; miz; PIASX ALPHA; PIASX BETA; zinc finger; MIZ type containing 4; ZMIZ4; DAB2-interacting protein; zinc finger, MIZ-type containing 4; msx-interacting zinc finger protein; protei;
PIAS3
protein inhibitor of activated STAT, 3
PIAS3; protein inhibitor of activated STAT, 3; E3 SUMO-protein ligase PIAS3; FLJ14651; zinc finger; MIZ type containing 5; ZMIZ5; zinc finger, MIZ-type containing 5; protein inhibitor of activated STAT protein 3;
PNPLA6
patatin-like phospholipase domain containing 6
PNPLA6; patatin-like phospholipase domain containing 6; neuropathy target esterase; NTE; sws; EC 3.1.1.5; NTEMND; Patatin like phospholipase domain containing 6; Patatin like phospholipase domain containing protein 6; Patatin-like phospholipase domain-containing protein 6; PLPL6_HUMAN; SPG39;
SLC2A10
solute carrier family 2 (facilitated glucose transporter), member 10
SLC2A10; solute carrier family 2 (facilitated glucose transporter), member 10; ATS; GLUT10; MGC126706; solute carrier family 2, facilitated glucose transporter member 10;
SLC2A2
solute carrier family 2 (facilitated glucose transporter), member 2
SLC2A2; solute carrier family 2 (facilitated glucose transporter), member 2; GLUT2; solute carrier family 2, facilitated glucose transporter member 2; GLUT-2; glucose transporter type 2, liver;
SSTR1
somatostatin receptor 1
SSTR1; somatostatin receptor 1; somatostatin receptor type 1; G-protein coupled receptor; SS1R; SS1-R; SRIF-2; SS-1-R;
TAF13
TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa
TAF13; TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa; TAF2K, TATA box binding protein (TBP) associated factor, RNA polymerase II, K, 18kD; transcription initiation factor TFIID subunit 13; TAFII18; MGC22425; TAF(II)18; TAF13 RNA polymerase II, TATA box binding protein (TBP) associated factor, 18kDa; TAF13_HUMAN; TAF2K; TAFII 18; TAFII-18; Transcription initiation factor TFIID 18 kDa subunit; OTTHUMP00000039343; OTTHUMP00000039344; transcription initiation factor TFIID 18 kD subunit; TATA box binding protein (TBP)-associated factor, RNA polymeras;
TAF7L
TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa
TAF7L; TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa; TAF2Q, TATA box binding protein (TBP) associated factor, RNA polymerase II, Q; transcription initiation factor TFIID subunit 7-like; cancer/testis antigen 40; CT40; FLJ23157; TAF2Q; TAF7 like RNA polymerase II, TATA box binding protein (TBP) associated factor; TATA box binding protein-associated factor, RNA polymerase II, Q; TBP associated factor, RNA polymerase II, Q; TBP-associated factor, RNA polymerase II, Q; RNA polymerase II TBP-associated factor subunit Q; TATA box-binding protein-associated factor 50 kDa; transcription initiation factor TFIID 50 kDa subunit;
TGM4
transglutaminase 4 (prostate)
TGM4; transglutaminase 4 (prostate); protein-glutamine gamma-glutamyltransferase 4; TGP; Dorsal prostate transglutaminase; Dorsal protein 1; Dp1; Fibrinoligase; Prostate specific transglutaminase; Prostate transglutaminase; Prostate-specific transglutaminase; Protein glutamine gamma glutamyltransferase 4; TG(P); TGase P; TGase-4; TGase4; TGM4_HUMAN; Transglutaminase P; Transglutaminase-4; OTTHUMP00000164127; hTGP;
XPA
xeroderma pigmentosum, complementation group A
XPA; xeroderma pigmentosum, complementation group A; DNA repair protein complementing XP-A cells; XP1; XPAC; excision repair-controlling; xeroderma pigmentosum group A-complementing protein;
D17Wsu104e
DNA segment, Chr 17, Wayne State University 104, expressed
D17WSU104E; DNA segment, Chr 17, Wayne State University 104, expressed; UPF0556 protein C19orf10 homolog; interleukin-25; stromal cell-derived growth factor SF20; Il25; IL-25; Ly6elg;
GPX2
glutathione peroxidase 2 (gastrointestinal)
GPX2; glutathione peroxidase 2 (gastrointestinal); glutathione peroxidase 2; GSHPX GI; Gastrointestinal glutathione peroxidase; GI GPx; Glutathione peroxidase gastrointestinal; Glutathione peroxidase related protein 2; Glutathione peroxidase-gastrointestinal; Glutathione peroxidase-related protein 2; GPRP; GPRP-2; GPx 2; GPx-2; GPx-GI; GPX2_HUMAN; GSHPx 2; GSHPx-2; GSHPx-GI; gastrointestinal glutathione peroxidase 2; GI-GPx;
PSA
prostate specific antigen
Alternative namesAPS; Gamma seminoprotein; Gamma-seminoprotein; hK3; Kallikrein 3; Kallikrein related peptidase 3; Kallikrein-3; KLK 3; KLK2A1; KLK3; KLK3_HUMAN; P 30 antigen; P-30 antigen; P30 antigen; Prostate Specific Antigen; Prostate-specific antigen; Psa; Semenogelase; Seminin;
NAT14
N-acetyltransferase 14 (GCN5-related, putative)
NAT14; N-acetyltransferase 14 (GCN5-related, putative); N acetyltransferase 14; N-acetyltransferase 14; K562 cells derived leucine zipper like protein 1; KLP1; K562 cell derived leucine zipper like protein 1; N acetyltransferase 14 (GCN5 related, putative); K562 cell-derived leucine-zipper-like protein 1; K562 cells-derived leucine zipper-like protein 1; K562 cells-derived leucine-zipper-like protein 1;
NME5
non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)
NME5; non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase homolog 5; nm23 H5; radial spoke 23 homolog (Chlamydomonas); RSPH23; NDK-H 5; IPIA-beta; NDP kinase homolog 5; radial spoke 23 homolog; testi;
NME7
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase)
NME7; non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 7; FLJ37194; NM23 H7; NDK 7; NDP kinase 7; nucleoside-diphosphate kinase 7; MN23H7; nm23-H7;
PHTF1
putative homeodomain transcription factor 1
PHTF1; putative homeodomain transcription factor 1; PHTF; Phft; OTTHUMP00000013561; OTTHUMP00000013562; OTTHUMP00000013565; OTTHUMP00000013566;
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1; APR; NOXA; protein Noxa; PMA-induced protein 1; immediate-early-response protein APR; adult T cell leukemia-derived PMA-responsive;
SLC1A6
Slc1a6 solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
SLC1A6; solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6; excitatory amino acid transporter 4; solute carrier family 1 member 6; solute carrier family 1, member 6; high-affinity neuronal glutamate transporter; sodium-dependent glutamate/aspartate transporter; EAAT4;
TMEFF1
transmembrane protein with EGF-like and two follistatin-like domains 1
TMEFF1; transmembrane protein with EGF-like and two follistatin-like domains 1; TR-1; H7365; C9orf2; CT120.1; tomoregulin-1; cancer/testis antigen family 120, member 1; transmembrane protein with EGF-like and one follistatin-like domain;
UBE2U
ubiquitin-conjugating enzyme E2U (putative)
UBE2U; ubiquitin-conjugating enzyme E2U (putative); ubiquitin-conjugating enzyme E2 U; ubiquitin-protein ligase U; ubiquitin carrier protein U;
UBE2W
ubiquitin-conjugating enzyme E2W (putative)
UBE2W; ubiquitin-conjugating enzyme E2W (putative); probable ubiquitin-conjugating enzyme E2 W; FLJ11011; hUBC 16; hUBC16; Probable ubiquitin conjugating enzyme E2 W; UBE 2W; UBE2W_HUMAN; Ubiquitin carrier protein W; Ubiquitin conjugating enzyme 16; Ubiquitin conjugating enzyme E2 W; Ubiquitin conjugating enzyme E2W; Ubiquitin protein ligase W; Ubiquitin-protein ligase W; OTTHUMP00000226882; OTTHUMP00000226883; ubiquitin-conjugating enzyme 16; UBC16; hUBC-16;
ERCC5
excision repair cross-complementing rodent repair deficiency, complementation group 5
ERCC5; excision repair cross-complementing rodent repair deficiency, complementation group 5; ERCM2, xeroderma pigmentosum, complementation group G , XPGC; DNA repair protein complementing XP-G cells; Cockayne syndrome; COFS 3; COFS3; DNA excision repair protein ERCC 5; DNA excision repair protein ERCC5; DNA repair protein complementing XP G cells; DNA repair protein complementing XPG cells; ERCC 5; ERCM 2; ERCM2; Excision Repair Cross Complementing Rodent Repair Deficiency; Excision repair cross complementing rodent repair deficiency complementation group 5; Excision repair protein; OTTHUMP00000064902; UVDR; Xeroderma Pigmentosum Complementation Group G; Xeroderma pigmentosum complementation group G protein; Xeroderma pigmentosum group G complementing protein; XPG; XPG complementing protein; XPGC; OTTHUMP00000018678; XPG-complementing protein; DNA excision repair protein ERCC-5; xeroderma pigmentosum, complementation group G;
FANCE
Fanconi anemia, complementation group E
FANCE; Fanconi anemia, complementation group E; FACE; Fanconi anemia group E protein; FAE; 2810451D06Rik; AI415634; AW209126; FANCE_HUMAN; Fanconi anemia complementation group E; Protein FACE; RGD1561045; OTTHUMP00000016254;
MUM1
melanoma associated antigen (mutated) 1
MUM1; melanoma associated antigen (mutated) 1; PWWP domain-containing protein MUM1; MUM 1; protein expandere; melanoma ubiquitous mutated protein; mutated melanoma-associated antigen 1; MUM-1; EXPAND1; HSPC211; FLJ14868; FLJ22283; MGC131891; MGC163315;
PIAS4
protein inhibitor of activated STAT, 4
PIAS4; protein inhibitor of activated STAT, 4; E3 SUMO-protein ligase PIAS4; FLJ12419; Piasg; PIASY; zinc finger; MIZ type containing 6; ZMIZ6; PIAS-gamma; zinc finger, MIZ-type containing 6; protein inhibitor of activated STAT protein 4; protein inhibito;
SST
somatostatin
Growth hormone release inhibiting factor; SMST; Somatostatin 14; Somatostatin 28; SST; somatostatin;
TAF15
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
TAF15; TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa; TAF2N, TATA box binding protein (TBP) associated factor, RNA polymerase II, N, 68kD (RNA binding protein 56); TATA-binding protein-associated factor 2N; hTAFII68; Npl3; RBP56; RNA binding protein 56; TAF; TAF2N; TAFII68; TAF(II)68; RBP56/CSMF fusion; TBP-associated factor 15; 68 kDa TATA-binding protein-associated factor; TATA box-binding protein-associated factor 2N (RNA-binding protein 56); TATA box binding protein (TBP)-associated f;
TAF1B
TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa
TAF1B; TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa; TATA box binding protein (TBP) associated factor, RNA polymerase I, B, 63kD; TATA box-binding protein-associated factor RNA polymerase I subunit B; RAF1B; RAFI63; SL1; TAFI63; TAF1B TATA box binding protein (TBP) associated factor, RNA polymerase I, B, 63kDa; TATA box binding protein associated factor 1B; TAB1 B; TATA box binding protein associated factor RNA polymerase I subunit B; SL1, 63kD subunit; OTTHUMP00000200348; TBP-associated factor 1B; TATA box-binding protein-associated factor 1B; transcription initiation factor SL1/TIF-IB subunit B; RNA polymerase I-specifi; MGC:9349;
TAF4B
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa
TAF4B; TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa; TAF2C2, TATA box binding protein (TBP) associated factor, RNA polymerase II, C2, 105kD; transcription initiation factor TFIID subunit 4B; TAFII105; TATA box binding;
TAF5
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa
TAF5; TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa; TAF2D, TATA box binding protein (TBP) associated factor, RNA polymerase II, D, 100kD; transcription initiation factor TFIID subunit 5; TAFII100; TAFII-100; TAF(II)100;
TAF9B
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa
TAF9B; TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa; TAF9 like RNA polymerase II, TATA box binding protein (TBP) associated factor, 31kDa , TAF9L; transcription initiation factor TFIID subunit 9B; DN 7; DN7; TAFII31L; TFIID 31; DN-7; Neuronal cell death related protein 7; Neuronal cell death-related protein 7; TAF9-like RNA polymerase II TBP associated factor, 31 kD; TAF9B_HUMAN; TAF9L; TFIID-31; Transcription initiation factor TFIID subunit 9-like; Transcription initiation factor TFIID subunit 9-like protein; Transcription-associated factor TAFII31L; OTTHUMP00000023594; TBP-associated factor 9L; transcription associated factor TAFII31L; transcription initiation factor IID, 31kD;
WFIKKN1
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
WFIKKN1; WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1; C16orf12, chromosome 16 open reading frame 12; WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1; RJD2; WFIKKN; C16orf12; Chromosome 16 open reading frame 12; GASP 2; GASP2; Growth and differentiation factor-associated serum protein; hGASP 2; WAP, follistatin/kazal, immunoglobulin, kunitz and netrin; WAP, FS, Ig, KU, and NTR containing protein; GASP-2; hGASP-2; OTTHUMP00000115417; WAP, FS, Ig, KU, and NTR-containing protein; growth and differentiation factor-associated serum protein 2; WAP, follistatin, immunoglobulin, kunitz and;
SSTR5
somatostatin receptor 5
SSTR5; somatostatin receptor 5; somatostatin receptor type 5; somatostatin receptor subtype 5; SS-5-R;
DUSP26
dual specificity phosphatase 26 (putative)
DUSP26; dual specificity phosphatase 26 (putative); dual specificity protein phosphatase 26; DUSP24; MGC1136; DSP-4; MKP-8; MAP kinase phosphatase 8; dual specificity phosphatase SKRP3; dual-specificity phosphatase SKRP3; mitogen-activated protein kinase;
GPX7
glutathione peroxidase 7
GPX7; glutathione peroxidase 7; FLJ14777; GPX6; NPGPx; CL683; GPx-7; GPX7_HUMAN; GSHPx-7; glutathione peroxidase 6; non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase;
MGST1
microsomal glutathione S-transferase 1
MGST1; microsomal glutathione S-transferase 1; GST12; MGST I; Glutathione S transferase 12; MGST 1; MGST; MGST1_HUMAN; Microsomal GST 1; Microsomal GST-1; Microsomal GST-I; glutathione S-transferase 12; MGST-I;
TARS2
threonyl-tRNA synthetase 2, mitochondrial (putative)
TARS2; threonyl-tRNA synthetase 2, mitochondrial (putative); TARSL1, threonyl tRNA synthetase like 1; threonyl-tRNA synthetase, mitochondrial; FLJ12528; threonine tRNA ligase 2; mitochondrial; Threonine tRNA ligase; ThrRS; TARS 2; TARSL1; Threonyl tRNA synthetase 2, mitochondrial; Threonyl tRNA synthetase like 1; threonine--tRNA ligase; threonyl-tRNA synthetase-like 1; threonine tRNA ligase 2, mitochondrial;
A1CF
APOBEC1 complementation factor
A1CF; APOBEC1 complementation factor; ACF; ACF64; ACF65; APOBEC1CF; ASP; apo-B RNA editing protein; APOBEC-1 stimulating protein; apobec-1 complementation factor (ACF) (ASP); RP11-564C4.2; MGC163391;
AARS2
alanyl-tRNA synthetase 2, mitochondrial (putative)
AARS2; alanyl-tRNA synthetase 2, mitochondrial (putative); AARSL, alanyl tRNA synthetase like; alanyl-tRNA synthetase, mitochondrial; alanine tRNA ligase 2; mitochondrial (putative); bA444E17.1; KIAA1270; AARSL; Gm89; MT ALARS; MTALARS; AARS 2; Alanine tRNA ligase 2 mitochondrial; Alanine tRNA ligase; Alanyl tRNA synthetase 2 mitochondrial; Alanyl tRNA synthetase like; AlaRS; MGC69820; Probable alanyl tRNA synthetase mitochondrial; RP11-444E17.1; alanine--tRNA ligase; alanyl-tRNA synthetase like; probable alanyl-tRNA synthetase, mitochondrial; alanine tRNA ligase 2, mitochondrial (putative); COXPD8; MT-ALARS;
APOBEC4
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative)
APOBEC4; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative); C1orf169, chromosome 1 open reading frame 169; putative C-> U-editing enzyme APOBEC-4; FLJ25691; MGC26594; RP1 127C7.4; a;
ASPHD2
aspartate beta-hydroxylase domain containing 2
ASPHD2; aspartate beta-hydroxylase domain containing 2; aspartate beta-hydroxylase domain-containing protein 2; FLJ39838;
TAT
tyrosine aminotransferase
TAT; tyrosine aminotransferase; tyrosine aminotransferase, cytosolic; L-tyrosine:2-oxoglutarate aminotransferase;
BOD1
biorientation of chromosomes in cell division 1
BOD1; biorientation of chromosomes in cell division 1; FAM44B, family with sequence similarity 44, member B; biorientation of chromosomes in cell division protein 1; biorientation defective 1; family with sequence similarity 44, member B; FAM44B;
ARSE
arylsulfatase E (chondrodysplasia punctata 1)
ARSE; arylsulfatase E (chondrodysplasia punctata 1); CDPX, CDPX1; arylsulfatase E; chondrodysplasia punctata 1; CDPX; CDPX1; CDPXR; MGC163310; OTTHUMP00000022851; ASE;
UBR7
ubiquitin protein ligase E3 component n-recognin 7 (putative)
UBR7; ubiquitin protein ligase E3 component n-recognin 7 (putative); C14orf130, chromosome 14 open reading frame 130; putative E3 ubiquitin-protein ligase UBR7; 5730410I19Rik; AA589405; AW557761; Chromosome 14 open reading frame 130; EC 6.3.2.-; FLJ10483; MGC94098; MGC9518; N recognin 7; RGD1359144; N-recognin-7; C14orf130;
RBFA
ribosome binding factor A (putative)
RBFA; ribosome binding factor A (putative); C18orf22, chromosome 18 open reading frame 22; putative ribosome-binding factor A, mitochondrial; FLJ21172; HsT169; Chromosome 18 open reading frame 22; Hypothetical protein LOC79863; Putative ribosome binding factor A, mitochondrial precursor; C18orf22;
CARS2
cysteinyl-tRNA synthetase 2, mitochondrial (putative)
CARS2; cysteinyl-tRNA synthetase 2, mitochondrial (putative); probable cysteinyl-tRNA synthetase, mitochondrial; cysteine tRNA ligase 2; mitochondrial (putative); FLJ12118; CARS 2; CysRS; Cysteine tRNA ligase 2 mitochondrial (putative); Cysteine tRNA ligase 2 mitochondrial; Cysteine tRNA ligase; Cysteinyl tRNA synthetase 2; Cysteinyl tRNA synthetase 2 mitochondrial (putative); Cysteinyl tRNA synthetase 2 mitochondrial; DKFZp667A2315; DKFZp686G08243; OTTHUMP00000018707; Probable cysteinyl tRNA synthetase mitochondrial; cysteine--tRNA ligase; cysteine tRNA ligase 2, mitochondrial (putative);
PARM1
prostate androgen-regulated mucin-like protein 1
PARM1; prostate androgen-regulated mucin-like protein 1; Castration induced prostatic apoptosis related protein 1; Cipar1; DKFZP564O0823; Prostatic androgen repressed message 1; WSC4; cell wall integrity and stress response component 4 homolog (S. cerevis;
TATDN1
TatD DNase domain containing 1
TATDN1; TatD DNase domain containing 1; putative deoxyribonuclease TATDN1; CDA11; hepatocarcinoma high expression protein; FLJ43280;
CST11
cystatin 11
CST11; cystatin 11; CST8L; cystatin-11; dJ322G13.6; CST11_HUMAN; cystatin related epididymal specific protein; SC13; SC13delta; cystatin-related epididymal-specific protein;
CST8
cystatin 8 (cystatin-related epididymal specific)
CST8; cystatin 8 (cystatin-related epididymal specific); cystatin-8; CRES; CST 8; CST8_HUMAN; cystatin 8 (cystatin related epididymal specific); Cystatin 8; Cystatin related epididymal specific; Cystatin related epididymal specific protein; Cystatin related epididymal spermatogenic protein; Cystatin related protein epididymis specific; Cystatin-related epididymal spermatogenic protein; cystatin-related epididymal-specific;
CST9L
cystatin 9-like
CST9L; cystatin 9-like; cystatin 9 (mouse) like; cystatin-9-like; bA218C14.1; testatin; FLJ92394;
AS3MT
arsenic (+3 oxidation state) methyltransferase
AS3MT; arsenic (+3 oxidation state) methyltransferase; arsenite methyltransferase; CYT19; methyltransferase cyt19; methylarsonite methyltransferase; S-adenosylmethionine:arsenic (III) methyltransferase; S-adenosyl-L-methionine:arsenic(III) methyltransfera;
FANCI
Fanconi anemia, complementation group I
FANCI; Fanconi anemia, complementation group I; KIAA1794; Fanconi anemia group I protein; FLJ10719; FLJ14658; Protein FANCI;
FANCL
Fanconi anemia, complementation group L
FANCL; Fanconi anemia, complementation group L; PHD finger protein 9 , PHF9; E3 ubiquitin-protein ligase FANCL; FAAP43; FLJ10335; Pog; FANCL_HUMAN; Fanconi anemia complementation group L; Fanconi anemia group L protein; Fanconi anemia-associated polypeptide of 43 kDa; PHD finger protein 9; PHF9; Ubiquitin ligase protein FANCL;
FANCM
Fanconi anemia, complementation group M
FANCM; Fanconi anemia, complementation group M; FAAP250; KIAA1596; Fanconi anemia group M protein; protein Hef ortholog; ATP-dependent RNA helicase FANCM; fanconi anemia-associated polypeptide of 250 kDa;
MFSD7B
major facilitator superfamily domain containing 7B
MFSD7B; major facilitator superfamily domain containing 7B; feline leukemia virus subgroup C receptor-related protein 1; Feline leukemia virus subgroup C cellular receptor; Feline leukemia virus subgroup C receptor; Feline leukemia virus subgroup C receptor related protein 1; FLVC1_HUMAN; FLVCR 1; FLVCR protein; FLVCR1; hFLVCR; eline leukemia virus subgroup C cellular receptor 1; feline leukemia virus subgroup C cellular receptor 1; FLVCR; 9630055N22Rik;
GSTO2
glutathione S-transferase omega 2
GSTO2; glutathione S-transferase omega 2; glutathione S-transferase omega-2; bA127L20.1; Glutathione S transferase like protein; Glutathione S transferase omega 2; GSTO 2; GSTO-2; GSTO2_HUMAN; glutathione-S-transferase-like protein; bA127L20.1 (novel glutathione-S-transferase);
FSTL4
follistatin-like 4
FSTL4; follistatin-like 4; follistatin-related protein 4; KIAA1061; Follistatin like 4; Follistatin related protein 4; FSTL 4; follistatin-like protein 4;
FSTL5
follistatin-like 5
FSTL5; follistatin-like 5; follistatin-related protein 5; DKFZp566D234; KIAA1263; 9130207J01Rik; Follistatin like 5; Follistatin-like protein 5; FSTL5_HUMAN;
NAT8L
N-acetyltransferase 8-like (GCN5-related, putative)
NAT8L; N-acetyltransferase 8-like (GCN5-related, putative); N acetyltransferase 8 like; N-acetylaspartate synthetase; FLJ37478; Hcml3; CML3; N acetyltransferase 8 like (GCN5 related, putative); NAT8 like; NAA synthetase; camello-like protein 3; NACED; NAT8-LIKE;
HARS2
histidyl-tRNA synthetase 2, mitochondrial (putative)
HARS2; histidyl-tRNA synthetase 2, mitochondrial (putative); HARSL, histidyl tRNA synthetase like; probable histidyl-tRNA synthetase, mitochondrial; HARSR; histidine tRNA ligase 2; mitochondrial (putative); HO3; Harsl; 4631412B19Rik; AI593507; HARS 2; HARS related; HisRS; Histidine translase; Histidine tRNA ligase; Histidine tRNA ligase homolog; Histidine tRNA ligase like; Histidyl tRNA synthetase 2 mitochondrial; Histidyl tRNA synthetase like; Probable histidyl tRNA synthetase mitochondrial; HARS-related; histidine-tRNA ligase homolog; histidine tRNA ligase 2, mitochondrial (putative);
SLC2A8
solute carrier family 2 (facilitated glucose transporter), member 8
SLC2A8; solute carrier family 2 (facilitated glucose transporter), member 8; solute carrier family 2 (facilitated glucose transporter) member 8; solute carrier family 2, facilitated glucose transporter member 8; GLUT8; GLUTX1; GLUT-8; glucose transporter;
SLC2A12
solute carrier family 2 (facilitated glucose transporter), member 12
SLC2A12; solute carrier family 2 (facilitated glucose transporter), member 12; GLUT8; GLUT12; solute carrier family 2, facilitated glucose transporter member 12; GLUT-12; glucose transporter type 12;
SLC2A9
solute carrier family 2 (facilitated glucose transporter), member 9
SLC2A9; solute carrier family 2 (facilitated glucose transporter), member 9; GLUT9; GLUTX; UAQTL2; URATv1; solute carrier family 2, facilitated glucose transporter member 9; GLUT-9; glucose transporter type 9; human glucose transporter-like protein-9; urate voltage-driven efflux transporter 1;
GRINA
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)
GRINA; glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding); NMDARA1; protein lifeguard 1; HNRGW; LFG1; TMBIM3; transmembrane BAX inhibitor motif containing 3; putative MAPK-activating protein PM02; NMDA receptor g;
HTATSF1
HIV-1 Tat specific factor 1
HTATSF1; HIV-1 Tat specific factor 1; HIV TAT specific factor 1; HIV Tat-specific factor 1; TAT SF1; cofactor required for Tat activation of HIV-1 transcription; TAT-SF1; dJ196E23.2;
GPX8
glutathione peroxidase 8 (putative)
GPX8; glutathione peroxidase 8 (putative); probable glutathione peroxidase 8; EPLA847; UNQ847; Glutathione peroxidase 8; GPX 8; GPx-8; GSHPx-8;
GR10A
Gustatory receptor 10a
GR10A; Gustatory receptor 10a; CG32664 gene product from transcript CG32664-RA; CG32664; Gr10B1; Putative gustatory receptor 10a; CG32664-PA; Gr10a-PA; gustatory receptor 10B1; Dmel\CG32664;
GR21A
Gustatory receptor 21a
GR21A; Gustatory receptor 21a; CG13948 gene product from transcript CG13948-RA; 21D.1; CG13948; Gr21D1; Putative gustatory receptor 21a; CG13948-PA; Gr21a-PA; gustatory receptor 21D.1; (GR) 21a; Dmel\CG13948; DmGr21a; GR21D.1;
GSTA5
glutathione S-transferase alpha 5
GSTA5; glutathione S-transferase alpha 5; glutathione S transferase A5; glutathione S-transferase A5; glutathione S transferase alpha 5; glutathione S transferase Yc 2; Glutathione S-transferase A5-5; GST A5 5; GST class-alpha member 5; GST Yc2; Gsta5 glutathione S transferase Yc2 subunit; GSTA5_HUMAN; glutathione transferase A5;
GSTCD
glutathione S-transferase, C-terminal domain containing
GSTCD; glutathione S-transferase, C-terminal domain containing; Glutathione S transferase, C terminal domain containing; glutathione S-transferase C-terminal domain-containing protein; FLJ13273; 4933434L15Rik; DKFZp686I10174; MGC74393; OTTMUSP00000027240; OTTMUSP00000027241; RGD1311822;
GTPBP10
GTP-binding protein 10 (putative)
GTPBP10; GTP-binding protein 10 (putative); GTP-binding protein 10; DKFZP686A10121; FLJ38242; protein obg homolog 2; ObgH2; UG0751c10; MGC104191;
GTPBP5
GTP binding protein 5 (putative)
GTPBP5; GTP binding protein 5 (putative); GTP-binding protein 5; dJ1005F21.2; FLJ10741; ObgH1; GTP binding protein 5; Protein obg homolog 1; GTP-binding protein 5 (putative);
GTPBP8
GTP-binding protein 8 (putative)
GTPBP8; GTP-binding protein 8 (putative); GTP-binding protein 8; HSPC135;
SLC2A14
solute carrier family 2 (facilitated glucose transporter), member 14
SLC2A14; solute carrier family 2 (facilitated glucose transporter), member 14; SLC2A3P3, solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 3; solute carrier family 2, facilitated glucose transporter member 14; GLUT14; DKFZp564K1672; Glucose transporter 14; GLUT3; SLC2A3P3; Solute carrier family 2 (facilitated glucose transporter), member 3; GLUT-14; glucose transporter type 14; solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 3;
GR22E
Gustatory receptor 22e
GR22E; Gustatory receptor 22e; CG31936 gene product from transcript CG31936-RA; CG31936-PA; Gr22e-PA; gustatory receptor 2940.1; CG31936; Dmel\CG31936; Gr2940.1;
HTN1
histatin 1
HTN1; histatin 1; histatin-1; HIS1; Histidine rich protein 1; Post PB protein; PPB; post-PB protein; histidine-rich protein 1;
IAH1
isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)
IAH1; isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae); isoamyl acetate-hydrolyzing esterase 1 homolog; IAH1_HUMAN; MGC102860;
LDHAL6A
lactate dehydrogenase A-like 6A
LDHAL6A; lactate dehydrogenase A-like 6A; L-lactate dehydrogenase A-like 6A; LDH6A; MGC23940; EC 1.1.1.27; L lactate dehydrogenase A like 6A; LDH6A_HUMAN;
LDHD
lactate dehydrogenase D
LDHD; lactate dehydrogenase D; probable D-lactate dehydrogenase, mitochondrial; D lactate dehydrogenase; DLD; MGC57726; D-lactate dehydrogenase;
ISWI
Imitation SWI
ISWI; Imitation SWI; ACF; anon-EP1279744.124; CG8625; CHRAC; dCHRAC; dISWI; Dmel\CG8625; dNURF; ISW; iswi; ISWI; NURF; Nurf-140; NURF-140; p140; p140/ISWI; SWI; CG8625-PA; CG8625-PB; CG8625-PC; ISWI ATPase; Iswi-PA; Iswi-PB; Iswi-PC; imitation SW; imitation SWI; imitation switch; imitation-SWI; nucleosome remodeling factor; nucleosome remodeling factor - 140kD;
MSMP
microseminoprotein, prostate associated
MSMP; microseminoprotein, prostate associated; prostate-associated microseminoprotein; PC 3; PSMP; MSMP_HUMAN; PC3 secreted microprotein homolog; PC3-secreted microprotein; Vmicroseminoprotein, prostate associated; PC3 prostate cancer cell-secreted microprotein;
LOC391764
putative TAF11-like protein ENSP00000332601-like
LOC391764; putative TAF11-like protein ENSP00000332601-like; Similar to hCG1989915;
EARS2
glutamyl-tRNA synthetase 2, mitochondrial (putative)
EARS2; glutamyl-tRNA synthetase 2, mitochondrial (putative); probable glutamyl-tRNA synthetase, mitochondrial; glutamate tRNA ligase 2; mitochondrial (putative); KIAA1970; MSE1; AL024049; mKIAA1970; 3230401I01Rik; EARS 2; GluRS; Glutamate--tRNA ligase; Probable glutamyl tRNA synthetase, mitochondrial; RGD1307904; glutamate tRNA ligase 2, mitochondrial;
LACE1
lactation elevated 1
LACE1; lactation elevated 1; lactation elevated protein 1; AFG1; ATPase family gene 1 homolog (S. cerevisiae); CG8520 gene product; ATPase family gene 1 homolog;
LLPH
LLP homolog, long-term synaptic facilitation (Aplysia)
LLPH; LLP homolog, long-term synaptic facilitation (Aplysia); C12orf31, chromosome 12 open reading frame 31; protein LLP homolog; hLLP; human LAPS18 like protein; MGC14817; C12orf31; Chromosome 12 open reading frame 31; Human LAPS18-like protein; LLPH_HUMAN; MGC104302; Protein LAPS18-like;
LRPPRC
leucine-rich pentatricopeptide repeat containing
LRPPRC; leucine-rich pentatricopeptide repeat containing; LSFC; GP130; LRP130; CLONE-23970; leucine-rich PPR motif-containing protein, mitochondrial; LRP 130; 130 kDa leucine-rich protein; leucine-rich PPR-motif containing; mitochondrial leucine-rich PPR motif-containing protein;
LYSMD2
LysM, putative peptidoglycan-binding, domain containing 2
LYSMD2; LysM, putative peptidoglycan-binding, domain containing 2; lysM and putative peptidoglycan-binding domain-containing protein 2; MGC35274; DKFZp686I2243; LysM and putative peptidoglycan binding domain containing protein 2; OTTHUMP00000162616;
LYSMD4
LysM, putative peptidoglycan-binding, domain containing 4
LYSMD4; LysM, putative peptidoglycan-binding, domain containing 4; lysM and putative peptidoglycan-binding domain-containing protein 4; FLJ33008; LysM putative peptidoglycan binding domain containing 4; MGC99501;
MUM1L1
melanoma associated antigen (mutated) 1-like 1
MUM1L1; melanoma associated antigen (mutated) 1-like 1; PWWP domain-containing protein MUM1L1; FLJ33516; MUM1-like protein 1; mutated melanoma-associated antigen 1-like protein 1; MGC129994; MGC129995;
MFSD1
major facilitator superfamily domain containing 1
MFSD1; major facilitator superfamily domain containing 1; major facilitator superfamily domain-containing protein 1; FLJ14153; UG0581B09; MFSD1_HUMAN; SMAP 4; SMAP-4; SMAP4; Smooth muscle cell-associated protein 4;
MFSD11
major facilitator superfamily domain containing 11
MFSD11; major facilitator superfamily domain containing 11; UNC93-like protein MFSD11; FLJ20226; FLJ22196; protein ET; major facilitator superfamily domain-containing protein 11; ET;
MFSD2B
major facilitator superfamily domain containing 2B
MFSD2B; major facilitator superfamily domain containing 2B; major facilitator superfamily domain-containing protein 2B; MFS2B_HUMAN;
MFSD3
major facilitator superfamily domain containing 3
MFSD3; major facilitator superfamily domain containing 3; major facilitator superfamily domain-containing protein 3; 2310010G13Rik; Major facilitator superfamily domain containing protein 3; MFSD 3; MGC114471;
MFSD6
major facilitator superfamily domain containing 6
MFSD6; major facilitator superfamily domain containing 6; major facilitator superfamily domain-containing protein 6; FLJ20160; macrophage MHC receptor 2; macrophage MHC class I receptor 2 homolog; MMR2; hMMR2;
MFSD8
major facilitator superfamily domain containing 8
MFSD8; major facilitator superfamily domain containing 8; ceroid lipofuscinosis, neuronal 7, late infantile, variant , CLN7; major facilitator superfamily domain-containing protein 8; MGC33302; ceroid-lipofuscinosis neuronal protein 7; ceroid-lipofuscinos;
MGAT4C
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)
MGAT4C; mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative); alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C; HGNT IV H; gnT-IVc; glcNAc-T IVc; N-acetylglucosaminyltransferase IVc; N-a;
NAT9
N-acetyltransferase 9 (GCN5-related, putative)
NAT9; N-acetyltransferase 9 (GCN5-related, putative); N acetyltransferase 9; N-acetyltransferase 9; DKFZP564C103; EBSP; Embryo brain specific protein; Nacetyltransferase 9; embryo brain-specific protein; EBSP, hNATL;
NARS2
asparaginyl-tRNA synthetase 2, mitochondrial (putative)
NARS2; asparaginyl-tRNA synthetase 2, mitochondrial (putative); probable asparaginyl-tRNA synthetase, mitochondrial; asparagine tRNA ligase 2; mitochondrial (putative); FLJ23441; SLM5; MGC125113; RGD1305145; AI875199; AsnRS; Asparagine tRNA ligase 2 mitochondrial; Asparagine tRNA ligase; Asparaginyl tRNA synthetase 2; Asparaginyl tRNA synthetase 2 mitochondrial; MGC41336; NARS 2; Probable asparaginyl tRNA synthetase; Probable asparaginyl tRNA synthetase mitochondrial; asparagine--tRNA ligase; asparagine tRNA ligase 2, mitochondrial (putative);
GRIN3A
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
GRIN3A; glutamate receptor, ionotropic, N-methyl-D-aspartate 3A; glutamate [NMDA] receptor subunit 3A; GluN3A; NMDAR3A; N-methyl-D-aspartate receptor subtype 3A; NR3A; NMDAR-L; FLJ45414;
GRIN3B
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
GRIN3B; glutamate receptor, ionotropic, N-methyl-D-aspartate 3B; NR3B; GluN3B; glutamate receptor ionotropic, NMDA 3B; NMDAR3B; NMDA receptor subunit 3B; glutamate [NMDA] receptor subunit 3B; N-methyl-D-aspartate receptor subtype 3B; NMDA type glutamate receptor subunit NR3B;
PCMTD2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
PCMTD2; protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2; C20orf36, chromosome 20 open reading frame 36; protein-L-isoaspartate O-methyltransferase domain-containing protein 2; FLJ10883; C20orf36; KIAA0835; KIAA1050; protein L isoaspartate (D aspartate) O methyltransferase domain containing 2;
PNPLA5
patatin-like phospholipase domain containing 5
PNPLA5; patatin-like phospholipase domain containing 5; patatin-like phospholipase domain-containing protein 5; dJ388M5.4; GS2L; 4833426H19Rik; dJ388M5; GS2 like protein; Patatin like phospholipase domain containing 5; Patatin like phospholipase domain containing protein 5; GS2-like protein;
PARS2
prolyl-tRNA synthetase 2, mitochondrial (putative)
PARS2; prolyl-tRNA synthetase 2, mitochondrial (putative); probable proline--tRNA ligase, mitochondrial; DKFZp727A071; proline tRNA ligase 2; mitochondrial (putative); proRS; proline--tRNA ligase; proline tRNA ligase 2, mitochondrial (putative); MT-PRORS;
PBOV1
prostate and breast cancer overexpressed 1
PBOV1; prostate and breast cancer overexpressed 1; prostate and breast cancer overexpressed gene 1 protein; UC28; UROC28; PBOV 1; dJ171N11.2;
PHTF2
putative homeodomain transcription factor 2
PHTF2; putative homeodomain transcription factor 2; DKFZp434D166; 9530062N20Rik; MGC86999; 1110054G21Rik; AI447096; C77923; DKFZp564F013; FLJ33324; OTTHUMP00000208227; OTTHUMP00000208228; OTTHUMP00000208229; OTTHUMP00000208230; OTTHUMP00000208231; OTTHUMP00000208232; OTTHUMP00000209950; PHTF2_HUMAN;
PNPLA1
patatin-like phospholipase domain containing 1
PNPLA1; patatin-like phospholipase domain containing 1; patatin-like phospholipase domain-containing protein 1; dJ50J22.1; FLJ38755; MGC119320; MGC119321; MGC119319; OTTHUMP00000016289; OTTMUSP00000028874; Patatin like phospholipase domain containing protein 1;
PNPLA4
patatin-like phospholipase domain containing 4
PNPLA4; patatin-like phospholipase domain containing 4; patatin-like phospholipase domain-containing protein 4; DXS1283E; GS2; IPLA2 eta; calcium independent phospholipases A2 eta;
PNPLA8
patatin-like phospholipase domain containing 8
PNPLA8; patatin-like phospholipase domain containing 8; calcium-independent phospholipase A2-gamma; IPLA2(GAMMA); IPLA2 2; IPLA2G; PNPLA-gamma; iPLA2 gamma; iPLA2-gamma; patatin-like phospholipase domain-containing protein 8; membrane-associated calcium-i;
PRAC
prostate cancer susceptibility candidate
PRAC; prostate cancer susceptibility candidate; C17orf92, chromosome 17 open reading frame 92; small nuclear protein PRAC; prostate; rectum and colon; prostate, rectum and colon expressed gene protein; C17orf92; MGC32520;
PTCD2
pentatricopeptide repeat domain 2
PTCD2; pentatricopeptide repeat domain 2; pentatricopeptide repeat-containing protein 2; FLJ12598;
PTCD3
Pentatricopeptide repeat domain 3
PTCD3; Pentatricopeptide repeat domain 3; pentatricopeptide repeat-containing protein 3, mitochondrial; DKFZp666K071; FLJ20758; Transformation related gene 15 protein; TRG15; TRG-15; transformation-related gene 15 protein;
PTOV1
prostate tumor overexpressed 1
PTOV1; prostate tumor overexpressed 1; prostate tumor-overexpressed gene 1 protein; ACID2; Activator interaction domain containing protein 2; Gcap3; Prostate tumor overexpressed gene 1; PTOV 1; activator interaction domain-containing protein 2; PTOV-1;
SACM1L
SAC1 suppressor of actin mutations 1-like (yeast)
SACM1L; SAC1 suppressor of actin mutations 1-like (yeast); phosphatidylinositide phosphatase SAC1; KIAA0851; SAC1; suppressor of actin 1; Suppressor of actin mutations 1-like protein;
SCARA5
scavenger receptor class A, member 5 (putative)
SCARA5; scavenger receptor class A, member 5 (putative); scavenger receptor class A member 5; FLJ23907; MGC45780; NET33; scavenger receptor hlg; testis expressed scavenger receptor; Tesr;
SCCPDH
saccharopine dehydrogenase (putative)
SCCPDH; saccharopine dehydrogenase (putative); probable saccharopine dehydrogenase; CGI 49; NET11; CGI49; FLJ43187; Saccharopine dehydrogenase; SCPDH_HUMAN; CGI-49; RP11-439E19.2;
SHOX
short stature homeobox
SHOX; short stature homeobox; short stature homeobox protein; GCFX; PHOG; SHOXY; SS; Growth control factor, X linked; Homo sapiens shox gene, alternatively spliced products, complete cds; Pseudoautosomal homeobox containing osteogenic; Pseudoautosomal homeobox containing osteogenic protein; Short stature homeobox containing protein; Turner syndrome; growth control factor, X-linked; short stature homeobox-containing protein; pseudoautosomal homeobox-containing osteogenic protein;
SLC25A12
solute carrier family 25 (aspartate/glutamate carrier), member 12
SLC25A12; solute carrier family 25 (aspartate/glutamate carrier), member 12; solute carrier family 25 (mitochondrial carrier, Aralar), member 12; calcium-binding mitochondrial carrier protein Aralar1; Aralar; araceli hiperlarga; mitochondrial aspartate gl;
SLC2A13
solute carrier family 2 (facilitated glucose transporter), member 13
SLC2A13; solute carrier family 2 (facilitated glucose transporter), member 13; proton myo-inositol cotransporter; H(+) myo inositol symporter; HMIT; H(+)-myo-inositol symporter; h(+)-myo-inositol cotransporter; proton (H+) myo-inositol symporter; MGC48624;
SPINK8
serine peptidase inhibitor, Kazal type 8 (putative)
SPINK8; serine peptidase inhibitor, Kazal type 8 (putative); serine protease inhibitor Kazal-type 8; ISK8_HUMAN;
SSTR3
somatostatin receptor 3
SSTR3; somatostatin receptor 3; somatostatin receptor type 3; OTTHUMP00000028737; Smstr3; Somatostatin receptor subtype 3; SS3R; SSR28; Sst3; SSTR 3; SS3-R; SS-3-R; SSR-28;
SSTR4
somatostatin receptor 4
SSTR4; somatostatin receptor 4; somatostatin receptor type 4; SS 4R; SS4R; SST R4; SSTR 4; SS4-R; SS-4-R; Somatostatin receptor subtype 4 Rattus norvegicus Sprague-Dawley major hippocampal somatostatin receptor (SSTR4) mRNA; Smstr4;
TAF3
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa
TAF3; TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa; TAF3 RNA polymerase II, TATA box binding protein (TBP) associated factor, 140 kD; transcription initiation factor TFIID subunit 3; TAF140; TAFII140; 140 kDa TATA box-binding protein-associated factor; Bip2 protein; TAF(II)14; TAF3 RNA polymerase II TATA box binding protein (TBP)-associated factor; TAFII155 protein; TBP-associated factor 3; Transcription initiation factor TFIID 140 kDa subunit; TAF(II)140; OTTHUMP00000019072; RNA polymerase II transcription factor TAFII140; TAFII-140;
TAF8
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa
TAF8; TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa; TATA box binding protein (TBP) associated factor, RNA polymerase II, A, 45/50kDa , taube nuss homolog (mouse) , TBN; transcription initiation factor TFIID subunit 8; FLJ32821; TAF(II)43; hTAFII43; Protein taube nuss; TAF8 RNA polymerase II, TATA box binding protein (TBP) associated factor, 43kDa; TAF8_HUMAN; TAFII-43; TAFII43; TATA box binding protein (TBP) associated factor, RNA polymerase II A 45/50kDa; Taube nuss homolog (mouse); TBN; TBP associated factor 8; TBP associated factor TAFII43; TBP associated factor, RNA polymerase II, 43 kD; TBP-associated factor 43 kDa; TBP-associated factor 8; Transcription initiation factor TFIID 43 kDa subunit; taube nuss homolog; TBP-associated factor TAFII43; TBP-associated factor, RNA polymerase II, 43 kD; TATA box binding protein (TBP)-associated factor, RNA polymerase II, A, 45/50kDa; 43; II; TAF;
TATDN3
TatD DNase domain containing 3
TATDN3; TatD DNase domain containing 3; putative deoxyribonuclease TATDN3; MGC142198;
XPNPEP3
X-prolyl aminopeptidase (aminopeptidase P) 3, putative
XPNPEP3; X-prolyl aminopeptidase (aminopeptidase P) 3, putative; probable Xaa-Pro aminopeptidase 3; APP3; NPHPL1; Aminopeptidase P3; OTTHUMP00000199806; Probable Xaa Pro aminopeptidase 3; X Pro aminopeptidase 3; X prolyl aminopeptidase (aminopeptidase P) 3; X-Pro aminopeptidase 3; XPP3_HUMAN;
UEVLD
UEV and lactate/malate dehyrogenase domains
UEVLD; UEV and lactate/malate dehyrogenase domains; ubiquitin-conjugating enzyme E2 variant 3; Attp; UEV3; 8430408E05Rik; EV and lactate malate dehydrogenase domain containing protein; EV and lactate/malate dehydrogenase domain-containing protein; FLJ11068; signaling molecule ATTP; ubiquitin conjugating enzyme E2 like; Ubiquitin conjugating enzyme E2 variant 3; Ubiquitin E2 variant and lactate/malate dehydrogenase domain containing protein; UEV 3; UEV and lactate malate dehyrogenase domains; UEV-3; UEV2 and LDH domains containing protein; UEVLD_HUMAN;
LZTS1
leucine zipper, putative tumor suppressor 1
LZTS1; leucine zipper, putative tumor suppressor 1; F37/Esophageal cancer related gene coding leucine zipper motif; leucine zipper putative tumor suppressor 1; FEZ1; F37; F37/esophageal cancer-related gene-coding leucine-zipper motif; LZTS1_HUMAN; Psdzip70;
GRIN2D
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
GRIN2D; glutamate receptor, ionotropic, N-methyl D-aspartate 2D; EB11; NR2D; GluN2D; NMDAR2D; glutamate receptor ionotropic, NMDA 2D; estrogen receptor binding CpG island; N-methyl D-aspartate receptor subtype 2D; N-methyl-d-aspartate receptor subunit 2D; glutamate [NMDA] receptor subunit epsilon-4;
CAND2
cullin-associated and neddylation-dissociated 2 (putative)
CAND2; cullin-associated; neddylation-dissociated 2 (putative); Tp120b; TIP120B; KIAA0667; cullin-associated NEDD8-dissociated protein 2; p120 CAND2; OTTHUMP00000207913; OTTHUMP00000209387; TBP interacting protein; TBP-interacting protein 120B; epididymis tissue protein Li 169; TBP-interacting protein of 120 kDa B; cullin-associated and neddylation-dissociated protein 2;
PRMT10
protein arginine methyltransferase 10 (putative)
PRMT10;protein arginine methyltransferase 10 (putative);25099;ENSG00000164169;4q31.23;FLJ46629;putative protein arginine N-methyltransferase 10;putative protein arginine N-methyltransferase 10;
LYSMD1
LysM, putative peptidoglycan-binding, domain containing 1
LYSMD1;LysM, putative peptidoglycan-binding, domain containing 1;32070;ENSG00000163155;SB145;RP11-68I18.5;1q21.3;MGC35223;lysM and putative peptidoglycan-binding domain-containing protein 1;lysM and putative peptidoglycan-binding domain-containing protein 1;
LYSMD3
LysM, putative peptidoglycan-binding, domain containing 3
LYSMD3;LysM, putative peptidoglycan-binding, domain containing 3;26969;ENSG00000176018;5q14.3;FLJ13542, DKFZp686F0735;lysM and putative peptidoglycan-binding domain-containing protein 3;lysM and putative peptidoglycan-binding domain-containing protein 3;
MFSD5
major facilitator superfamily domain containing 5
MFSD5;major facilitator superfamily domain containing 5;28156;ENSG00000182544;12q13.13;MGC11308;major facilitator superfamily domain-containing protein 5;major facilitator superfamily domain-containing protein 5;
MFSD7
major facilitator superfamily domain containing 7
MFSD7;major facilitator superfamily domain containing 7;26177;ENSG00000169026;LP2561;4p16.3;FLJ22269;major facilitator superfamily domain-containing protein 7;major facilitator superfamily domain-containing protein 7;MYL5;myosin light polypeptide 5 regulatory protein;
MFSD6L
major facilitator superfamily domain containing 6-like
MFSD6L;major facilitator superfamily domain containing 6-like;26656;ENSG00000185156;17p13.1;FLJ35773;major facilitator superfamily domain-containing protein 6-like;major facilitator superfamily domain-containing protein 6-like;
PATE4
prostate and testis expressed 4
PATE4;prostate and testis expressed 4;35427;ENSG00000237353;PATE-B;11q24.2;FLJ41047;prostate and testis expressed protein 4;prostate and testis expressed protein 4;PATE-like protein B;prostate and testis expression B;
PNPLA7
patatin-like phospholipase domain containing 7
PNPLA7;patatin-like phospholipase domain containing 7;24768;ENSG00000130653;NTEL1;NTE-R1;C9orf111;RP11-48C7.2;9q34.3;FLJ31318, FLJ43070, FLJ44279;patatin-like phospholipase domain-containing protein 7;patatin-like phospholipase domain-containing protein 7;
RTTN
rotatin
RTTN;rotatin;18654;ENSG00000176225;18q22.2;FLJ26356, FLJ39085, DKFZp434G145;rotatin;rotatin;
SLC2A7
solute carrier family 2 (facilitated glucose transporter), member 7
SLC2A7;solute carrier family 2 (facilitated glucose transporter), member 7;13445;ENSG00000197241;GLUT7;1p36.2;solute carrier family 2, facilitated glucose transporter member 7;solute carrier family 2, facilitated glucose transporter member 7;GLUT-7;glucose transporter type 7;intestinal facilitative glucose transporter 7;
SPINK13
serine peptidase inhibitor, Kazal type 13 (putative)
SPINK13;serine peptidase inhibitor, Kazal type 13 (putative);27200;ENSG00000214510;LiESP6;SPINK5L3;HESPINTOR;HBVDNAPTP1;5q32;MGC149260;serine protease inhibitor Kazal-type 13;serine protease inhibitor Kazal-type 13;serine protease inhibitor Kazal-type 5-like 3;hepatitis B virus DNA polymerase transactivated serine protease inhibitor;hepatitis B virus DNA polymerase transactivated human serine protease inhibitor;
SPINK7
serine peptidase inhibitor, Kazal type 7 (putative)
SPINK7; serine peptidase inhibitor, Kazal type 7 (putative); 24643; ENSG00000145879; ECG2; ECRG2; 5q32; MGC133105, MGC133106; serine protease inhibitor Kazal-type 7; ECRG-2; esophagus cancer related gene 2; esophagus cancer-related gene-2; esophagus cancer-related gene 2 protein;
STMN4
stathmin-like 4
STMN4;stathmin-like 4;16078;ENSG00000015592;RB3;8p21.2;MGC111012;stathmin-4;stathmin-4;stathmin-like protein B3;stathmin-like-protein RB3;
TATDN2
TatD DNase domain containing 2
TATDN2;TatD DNase domain containing 2;28988;ENSG00000157014;3p25.3;KIAA0218, MGC126819, MGC126825;putative deoxyribonuclease TATDN2;putative deoxyribonuclease TATDN2;
TMF1
TATA element modulatory factor 1
TMF1;TATA element modulatory factor 1;11870;ENSG00000144747;TMF;ARA160;3p21-p12;TATA element modulatory factor;TATA element modulatory factor;androgen receptor coactivator 160 kDa protein;androgen receptor-associated protein of 160 kDa;
SLC2A11
solute carrier family 2 (facilitated glucose transporter), member 11
SLC2A11;solute carrier family 2 (facilitated glucose transporter), member 11;14239;ENSG00000133460;GLUT10;GLUT11;SLC2A11-a;SLC2A11-c;22q11.23;MGC118830, MGC118833;solute carrier family 2, facilitated glucose transporter member 11;solute carrier family 2, facilitated glucose transporter member 11;GLUT-10;GLUT-11;glucose transporter type 10;glucose transporter type 11;glucose transporter protein 10;glucose transporter protein 11;glucose transporter-like protein XI;facilitative glucose transporter GLUT11;
YBEY
ybeY metallopeptidase (putative)
YBEY;ybeY metallopeptidase (putative);1299;ENSG00000182362;C21orf57;21q22.3;FLJ46907;rRNA maturation factor homolog;rRNA maturation factor homolog;putative metalloprotease C21orf57;
NAT16
N-acetyltransferase 16 (GCN5-related, putative)
NAT16;N-acetyltransferase 16 (GCN5-related, putative);22030;ENSG00000167011;C7orf52;7q22.1;FLJ39237, DKFZp547K159;putative N-acetyltransferase 16;putative N-acetyltransferase 16;putative N-acetyltransferase C7orf52;
BOD1L1
biorientation of chromosomes in cell division 1-like 1
BOD1L1;biorientation of chromosomes in cell division 1-like 1;31792;ENSG00000038219;BOD1L;FAM44A;4p16.1;FLJ33215, KIAA1327;biorientation of chromosomes in cell division protein 1-like 1;biorientation of chromosomes in cell division protein 1-like 1;family with sequence similarity 44, member A;
PCMTD1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
PCMTD1;protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1;30483;ENSG00000168300;8q11.23;FLJ10883;protein-L-isoaspartate O-methyltransferase domain-containing protein 1;protein-L-isoaspartate O-methyltransferase domain-containing protein 1;
BOD1L
biorientation of chromosomes in cell division 1-like
FAM44A; AI853319; mKIAA1327; A230054D04Rik;
D10Wsu52e
DNA segment, Chr 10, Wayne State University 52, expressed
FAAP; HSPC117; AI255213; AI463255;
D6Wsu116e
DNA segment, Chr 6, Wayne State University 116, expressed
Fam21; A130095H06; C530005J20Rik;
RGD1565734_predicted
excision repair cross-complementing rodent repair deficiency complementation group 6 - like
RGD1565734;
RGD1309228
similar to putative protein, with at least 9 transmembrane domains, of eukaryotic origin (43.9 kD) (2G415)
Enpp4
ENPP4 ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) [ Homo sapiens ]
ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative); 3359; Ensembl:ENSG00000001561; KIAA0879; ectonucleotide pyrophosphatase/phosphodiesterase family member 4; NPP-4; E-NPP 4; ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function); 3.1.-.-; NPP4;
Gtpbp6
GTPBP6 GTP binding protein 6 (putative) [ Homo sapiens ]
GTP binding protein 6 (putative); 30189; Ensembl:ENSG00000178605; FLJ20977, FLJ22809, FLJ56662, FLJ56805, FLJ90047; putative GTP-binding protein 6; PGPL;
LOC501110
similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon) (GSTA1-1) (GST class-alpha)
Sstr2
somatostatin receptor 2
Somatostatin receptor type 2; SRIF-1; SRIF1; SS-2-R; SS2-R; SS2R; SSR2_HUMAN; SST2; SSTR2;
GDEP
GDEP gene differentially expressed in prostate [ Homo sapiens (human) ]
PCAN1; gene differentially expressed in prostate; Prostate cancer protein 1; GDEP;
Protein Quantitation Service
By many years of experience in protein researches, Creative BioMart provides a comprehensive range of analytical development and testing services for protein quantitation. Our testing services provide high-quality analysis required throughout discovery, development, clinical trials, and commercial...
Co-Immunoprecipitation (Co-IP) Service
Many protein-protein associations that exist within the cell remain intact when a cell is lysed under non-denaturing conditions. Co-immunoprecipitation, advanced technique developed from immunoprecipitation, is the most straightforward way to determine whether two proteins of interest are physiologi...
Bladder Cancer-related Gene Mutation was Identified
The finding comes from an international research associated with bladder carcinoma-related gene mutation. In some way, the finding stresses the importance of genetic test for prevention. The research was later published on Nature Genetics. During the study, researchers f...
Christmas Presentation for Customers from Creative BioMart
At the time of giving and sharing with wishes of all joys in the Christmas season, Creative BioMart is going to present customers its precious Cell Line Development service. Usingproprietary technologies, such as codon optimization and vector design technologies, Creative BioMart offers Ready...
Orientation of Antibody with Localized Infection and Systemic Infection
According to a study published in the Journal of Experimental Medicine on December 10th, the orientation of antibody binding to bacteria might decide the life or death to the bug. The new study is led by Pontus Nordenfelt of Harvard University and his colleagues at Lund University in Sweden. These f...
One of the 54th ASH Annual Meeting Presentations: SGEN' Antibody-drug Conjugate Hit a Hope for the Treatment of AML
This year as usual on the 54th American Society of Hematology (ASH) annual meeting, there were lot of new findings and explorations were presented and shared. One of them, the Seattle Genetics ($SGEN) gave a brief presentations on SGN-CD33A, which is one of its early-stage next-generation antibody-d...
Stat5 Protein is an Important Target for the Research of Prostate Cancer
Among many factors that affect prostate cancer, Stat5 is one of the important. As early as in 2003, scientists have discovered that Stat5 protein is critical for viability of prostate cancer cells and growth of prostate tumors in mice. In 2005, researchers demonstrated that Stat5 activity was assoc...
CD44, CD47 and MET Have been Found Related to Initiation of Metastatic Cancer Cells
Circulating tumor cells (CTCs) are now treated as a biomarker for prognosis and people think the CTCs are connected to cancer metastasis. But there is no clear clue to clarify how CTCs affect patients. Some scientists thought only few CTCs will form secondary tumor in different organs as the metast...
New Product: Native Lactate Dehydrogenase and the Property
In 1970s, human Lactate Dehydrogenase was broadly reported in studies and literatures, which indicated its great potential. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria. ...
Statistics: Research Focus Is Put on Recombinant Proteins
According to the results of one of our online surveys, most listed companies have placed their emphasis on the development of recombinant proteins. Meanwhile according to the statistics of financial weekly newspaper, nine pharmaceutical...
Chromatin Immunoprecipitation (ChIP)
Chromatin Immunoprecipitation (ChIP) principle and introduction Chromatin immunoprecipitation (ChIP) has become an important and popular method for the study of DNA-protein interactions. During the ChIP experiment, protein complexes that interact with DNA are cross-linked to their binding sites...
Immunoprecipitation
Principle Crosslink immunoprecipitation refers to the process of antigen purification utilising a specific antibody. The principle involves crosslinking to covalently attach a specific antibody to a protein A agarose resin (recombinant protein combining antibody-binding domains from protein A), w...
Principle and Protocol of Co-Immunoprecipitation
Co-Immunoprecipitation (Co-IP) was developed from the immunoprecipitation technique with which Co-IP shares the fundamental principle of the specific antigen-antibody reaction. Immunoprecipitation(IP) technique is used for isolate individual protein. Using an antibody that is specific for a particul...
Real-time Quantitative PCR
BACKGROUND A protein expression needs gene transcription and translation. Whether gene transcription or the quantity of gene transcription clearly reflect the protein expression level. Therefore, its critical for the information of protein expression to detect the quantity of target gene transc...
RNA Binding Protein Immunoprecipitation (RIP)
Background The discovery of non-coding RNA makes RNA become the focus of life science research once again. Because RNA is an unstable biological macromolecule, most RNAs need to be bound to a specific RNA-binding protein to form an RNA / prot...
Crosslinking and ImmunoPrecipitation (CLIP)
Principle Ultraviolet (UV) crosslinking is a classical in vitro tool used by RNA biochemists to study RNAprotein complexes in living tissues. Scientists have successfully used CLIP (crosslinking and immunoprecipitation of RNAprotein complexes) to identify a number of target RNAs of the Nova famil...
Fast Chromatin Immunoprecipitation Assay
1. Introduction The chromatin immunoprecipitation assay (ChIP assay) has greatly facilitated the expansion of our knowledge of the proteinDNA interactions involved in regulating gene expression, DNA repair, and cell division. The function of the assay is that it gives a researcher the ability to ...
What is STAT1 Protein
See All STAT1 Protein Products Signal transducer and activator of transcription 1 (STAT1) is a key protein in cellular signaling, coordinating responses to extracellular signals. STAT1 is a transcription factor in the JAK-STAT signaling pathway that converts external signals into cellular responses....
What is STAT3 Protein
See All STAT3 Protein Products In the complex tapestry of cellular signaling, the Signal Transducer and Activator of Transcription 3 (STAT3) protein emerges as a pivotal player, orchestrating responses to extracellular cues. What is STAT3 Protein? The STAT3 protein, a member of the STAT protein fa...
JAK-STAT Signal Pathway
JAK-STAT signal pathway is a cytokine-stimulated signal transduction pathway found in recent years. It is involved in many important biological processes such as cell proliferation, differentiation, apoptosis and immune regulation. Compared with other signaling, the JAK-STAT signal pathway is re...
